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ABSTRACT 
 
The cerebellum is the most commonly reported brain region to 
demonstrate pathology in autism.  Multiple reports have indicated a lower 
density of Purkinje cells (PCs) in the posterolateral cerebellar hemispheres.  We 
performed a stereological technique to precisely quantify PCs in postmortem 
autism cases compared to age- and sex-matched controls. We found that 
although PC density was lower in all cerebellar regions studied, the most 
significant difference was in lobule VIIa of the posterior lobe.  The PCs in this 
region project to deep cerebellar nuclei that reciprocally connect to all aspects of 
the established broader sensorimotor gating network.  Sensorimotor gating 
abnormalities are commonly observed in individuals diagnosed with autism, 
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and may contribute to problems with sensory processing and behavioral 
inhibition in these individuals.  We studied a rat model of sensorimotor gating 
impairment, in which the histamine H1 receptor antagonist, pyrilamine, 
improved sensorimotor gating.  Using autoradiography, we found that 
pyrilamine treatment altered H1 receptor and α7 nicotinic receptor binding in 
the anterior cingulate and insular cortex, respectively, an effect which correlated 
with improved sensorimotor gating.  Histamine functions as both a 
neurotransmitter as well as a regulator of glial activity throughout the brain.  
Using western blots, we quantified H1 receptor levels in lobule VIIa from 
postmortem autism cases but found no difference compared to controls.  We 
further quantified additional proteins to investigate theories of neuroimmune 
and neuroendocrine dysregulation in the cerebellum in autism.  These included 
IBA-1, GFAP, IL-6, androgen receptor, estrogen receptor β, and aromatase.  We 
found no evidence to support these theories: all protein levels tested were found 
to be similar in the autism and control groups. We suggest further studies to 
better understand cerebellar pathogenesis and regulation of sensorimotor gating 
in autism.  The implications of sensorimotor gating impairment in autism are 
discussed in relation to the established symptomatology of this 
neurodevelopmental behavioral disorder. 
 vii 
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INTRODUCTION 
History of Cerebellar Pathological Findings in Autism 
 The cerebellum is the brain region most consistently reported to display 
pathology in autism.  In an initial case report from a postmortem 
histopathological investigation (Bauman and Kemper, 1985), members of our 
group identified potential pathologies in the hippocampus, subiculum, 
entorhinal cortex, septal nuclei, mamillary body, amygdala, neocerebellar cortex, 
cerebellar deep nuclei, and inferior olivary nucleus.  As a variety of methods 
have subsequently been employed and numerous studies undertaken, the list of 
observed brain pathologies and regions implicated in autism continues to grow.  
Nonetheless, as discussed in detail in Chapter 1, a compelling finding is that the 
majority of cerebellar neuropathology studies to date have demonstrated a lower 
Purkinje cell (PC) density in autism, most prevalent in the posterior lobe and 
archicerebellum (Ritvo et al. 1986, Kemper and Bauman 1993, Bailey et al. 1998, 
Lee et al. 2002, Vargas et al. 2005, Whitney et al. 2008).  Additionally, early cases 
analyzed displayed age-dependent volumetric changes in neuronal volumes 
within the associated deep cerebellar nuclei.  
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 Despite early attempts to place a developmental timepoint on the PC 
density alterations observed in autism, it is still not entirely clear if PC density is 
solely affected in prenatal and early postnatal development, or if PCs are 
continually lost throughout life.  As described in Chapter 1, we failed to notice an 
increased trajectory of the normal age-dependent decline in PC density in 
autism.   A few lines of evidence have supported the theory that PCs are 
principally lost (or fail to develop to their typical density) in prenatal 
development, prior to their maturation and the establishment of dependent 
connectivity with the molecular layer interneurons, granule cells, and inferior 
olivary afferents.  It has been theorized that after the final weeks of prenatal 
development, an intimate 1-to-1 relationship between PCs and inferior olivary 
neurons is established such that loss of PCs would result in parallel inferior 
olivary neuronal loss, which has not been observed in autism (Whitney et al. 
2009).  While historic studies seemed to indicate that inferior olivary neuronal 
survival in humans was dependent on survival of associated PCs following 
prenatal development, these early studies lacked the methodology to directly 
investigate this phenomenon precisely.  In fact, a precise stereological study of 
inferior olivary neuron numbers in humans has not been reported (to justify the 
theory of a 1-to-1 relationship with the PC population).  In order to clearly 
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establish the dependence of inferior olivary neuronal survival on PCs 
postnatally, studies had to be designed to selectively target PC degeneration 
without otherwise impacting associated neuronal populations.  Pharmacological 
advances have brought us closer to designing such a methodology, but 
complications still exist.  For instance, somewhat selective targeted viral vectors 
that administer genetic signals to PCs have been devised (Goenawan and Hirai 
2012), but these approaches can still generate nonspecific effects and are still in 
their infancy.  More established however, are the mutant mouse models where a 
selective mutation is seen to predominantly affect PC survival.  In such mutant 
mice, PCs are seen to degenerate at specific developmental timepoints, and the 
effect of PC loss on associated cells has been an active area of research.  Once it is 
established that an associated cell population is affected subsequent to PC loss in 
these models, it is further necessary to demonstrate that the mutation alone did 
not affect the survival of these associated cells: which is now being proven using 
isolated in vitro cell cultures of the typically associated cells bearing the mutant 
gene.  Using these approaches, a more complicated relationship between PC and 
inferior olivary neuron survival is beginning to be elucidated: it appears that in a 
specific critical developmental window, PC loss does indeed result in a parallel 
loss of inferior olivary neurons.  For instance, in some of the classic cerebellar 
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mutant mouse strains, staggerer and lurcher, which both display 80-100% loss of 
PCs prenatally and early postnatally (Caddy and Biscoe 1979, Herrup and 
Mullen 1979, Doulazmi et al. 2001), researchers have observed a parallel and 
similarly extensive loss of granule cells that is not due to the mutation alone but 
rather the loss of their PC afferents (Wetts and Herrup 1982, Zanjani et al. 2007).  
In both of these mutant strains, 60-90% of inferior olivary neurons are lost as well 
(Herrup 1983, Wetts and Herrup 1982, Shojaeian et al. 1985).  Interestingly 
however, following this critical developmental window, research is beginning to 
indicate that inferior olivary neurons are spared despite targeted PC loss 
(Zanjani et al. 2004): in the nervous and leaner mutant mice, in which PC loss 
begins later postnatally, inferior olivary neuronal loss is much more limited to 
30% in the nervous mutants who show PC loss beginning around P20 (Manto 
and Pandolfo 2002) and virtually no olivary neuron loss is seen in the leaner 
mutants whose PCs are lost later and more gradually for the first year of life 
(Sidman et al. 1965, Herrup and Wilczynski 1982, Frank et al. 2003).  Both the 
nervous and leaner mutants display substantial PC loss similar in extent to the 
staggerer and lurcher mutants, but the key difference is when this loss occurs.  
Unfortunately, studies of granule cell density in autism have been less feasible—
it is extremely difficult to accurately quantify these neurons in humans as they 
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are small and incredibly densely packed within the granule cell layer, which 
contains more neurons than the entire rest of the brain and spinal cord combined 
(Herculano-Houzel and Lent 2005).  However, more recent work by members of 
our group has determined that basket and stellate cell density in the cerebellar 
molecular layer are not affected in the autism cases analyzed, despite observable 
decreases in PC density (Whitney et al. 2009), indicating that PC development is 
normal until at least the last weeks of gestation when these interneurons develop 
alongside the established PCs.  It must be emphasized though that our 
observations have been based on relatively small human sample sizes, and it is 
further possible that in autism these developmental timepoints and the survival 
dependency of associated neuronal networks may be perturbed.  Indeed, some 
investigators have noted PCs in autism displaying more than a single climbing 
fiber (personal communications with Dr. Gene Blatt), which is clear evidence of a 
developmental perturbation of the establishment of the typical relationship 
between PCs and inferior olivary neurons.  Therefore, based on our limited 
methodology, it is impossible to determine the precise timing of the alteration in 
PC density in autism.    However, as discussed below, there is sufficient evidence 
to indicate that there isconsiderable strain on PCs in autism that would be 
expected to impact the functionality of these cells throughout life. 
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Purkinje cells are large projection neurons that summate the information 
received from over 100,000 excitatory connections and local inhibitory 
interneuron connections (Kern 2003) into a complex action potential spiking 
pattern. This pattern indicates the relative level of excitation and inhibition, and 
also the amplitude of any changes in excitation or inhibition (Gauck and Jaeger 
2000, Palmer et al. 2010).  As such, they display significant metabolic demands 
and are highly prone to excitotoxicity (Slemmer et al. 2005).  Heightened 
metabolic demands lead to the creation of reactive oxygen species (ROS) within 
the mitochondria that damage crucial biomolecules and contribute to cellular 
stress (Carriedo et al. 1998).  Furthermore, it has been demonstrated that 
individuals with autism display increased oxidative damage throughout the 
body, including the cerebellum (Kern and Jones 2006, Sajdel-Sulkowska et al. 
2009, Chauhan et al. 2011), in part due to decreased antioxidant capacity (Rose et 
al. 2012).  If local cellular stress signals begin to outweigh the neurotrophic and 
pro-survival signals, a neuron will undergo apoptosis (Kültz 2005, Higgins et al. 
2010).  Thus, PCs are particularly sensitive to physiological alterations that could 
negatively impact neuronal survival.   
Apart from inducing local damage to proteins, DNA, and vital membrane 
lipids, ROS also play an important role in the innate immune response.  When in 
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excess, ROS are capable of initiating or at least perpetuating an immunological 
reaction in the brain (Kohchi  et al. 2009, Murphy and Siegel 2013).  In autism, 
there are many lines of evidence that support the theory of neuroimmune 
dysregulation contributing to the pathophysiology of the disorder.  In a Danish 
study of 3325 children diagnosed with autism, researchers identified a wide 
variety of autoimmune conditions that were significantly more prevalent in the 
family histories of the autism group compared to the overall population 
(Atladóttir et al. 2009).   Autoantibodies to cerebellar GABAergic interneurons 
and Golgi cells (and a variety of other interneurons throughout the brain) have 
been identified in a subset (approximately 20%) of individuals with autism (Wills 
et al. 2009 & 2011).  These antibodies are evidence of an altered peripheral 
immune profile in autism, which has been further characterized by studies 
demonstrating imbalances of immune signaling molecules and alterations in 
lymphocyte responses that are expected to favor inflammatory processes 
(Ashwood et al. 2006).  Indeed, in the cerebellum in autism (as well as other 
implicated brain regions), researchers have demonstrated increased microglial 
and astrocyte proliferation, as well as increased proinflammatory cytokine 
expression (Vargas et al. 2005).  Thus, in the context of a system-wide 
neuroimmune dysregulation in autism, the cerebellum is a site of increased 
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susceptibility to neuroinflammation and preliminary evidence has supported this 
theory in a subset of individuals.   
As described below in Chapter 3, we attempted to investigate this theory 
by performing western blots to quantify key proteins implicated in this 
neuroimmune dysregulation within cerebellar lobule VIIa.  We did not find 
evidence of immune or glial purturbations.  Furthermore, in our PC density 
measurements from this same region, although we demonstrated that lobule VIIa 
(as hypothesized) was the site of the greatest difference in PC density in autism, 
we failed to recognize an age-dependent decline in PC density as a result of the 
disorder.  Nonetheless, immune complications do appear to affect a 
subpopulation of individuals diagnosed with autism, and a better understanding 
of the neuroimmune impact on brain development and neuronal function 
throughout life may lead to the discovery of important interventions that could 
be beneficial to a subset of individuals on the spectrum. 
An additional pathophysiological challenge in the cerebellum in autism, 
which would be expected to directly affect the information processing therein, is 
an imbalance of neurotransmitter signaling via many of the neurochemical 
pathways investigated to date.  A primary emphasis has been placed on the 
theory that excitatory/inhibitory balance is offset in the cerebellum and many 
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other brain regions studied, in favor of increased neuronal excitation (Baroncelli 
et al. 2011).  Specifically, decreased expression of the enzymes responsible for 
converting the main excitatory neurotransmitter, glutamate, into the main 
inhibitory neurotransmitter, GABA, has been observed in postmortem cerebellar 
samples from individuals with autism at the mRNA and protein levels (Fatemi et 
al. 2002, Yip et al. 2007).  Additionally, decreased cerebellar expression of 
GABAB receptor mRNA and protein has been reported in autism (Fatemi et al. 
2010).  GABAB receptors are an important class of metabotropic inhibitory 
receptor that regulates the excitability of PCs (Vigot and Batini 1997, Tabata and 
Kano 2006).  Moreover, other neurotransmitter systems appear to be impacted in 
the cerebellum in autism: altered expression of nicotinic cholinergic receptors 
(Lee et al. 2002) and increases in the 5-HT5A serotonin receptor (Marazziti 2002) 
have been identified.  However, the relevance of these cholinergic and 
serotonergic abnormalities in the context of brain pathology or autism 
symptomatology is less clear than is the case with GABA and glutamate. 
 Apart from volumetric changes observed in the neurons of the deep 
cerebellar nuclei and inferior olive as mentioned above, the PCs in autism have 
also been reported to display a 25% lower somal volume (Fatemi et al. 2002, 
Wegiel et al. 2013).  Neurons in the deep nuclei of the cerebellum were reported 
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to initially swell but then shrink with age (Kemper and Bauman 1998).  This 
appears to follow the pattern of overall brain volume changes observed in 
autism, whereby early brain development is marked by increased overall brain 
growth (with correlative changes in cerebellar volume), and subsequently 
decreased growth later in life (Courchesne 2004).  At this macroscopic level, 
structural MRI data from individuals with autism has been inconclusive, with 
some individuals displaying hypoplasia and others displaying hyperplasia of the 
vermis (Courchesne et al. 1994).   
One of the most important factors to keep in mind when interpreting 
cerebellar developmental neuropathology is the reciprocal relationship with 
most other brain regions to which the cerebellum connects.  In complex multi-
system disorders like autism, a clear connection between cerebellar pathology 
and behavioral symptomatology is not readily achieved.  Further research will be 
necessary with more precisely quantified behavioral data to determine the 
potential role of cerebellar pathology in autism symptomatology. 
 
Our Findings of Regional Alterations in PC density 
Chapter 1 describes a stereological investigation we undertook to 
determine regional PC density in autism in comparison to age- and sex-matched 
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controls—it was the most thorough and quantitative to date to address this issue, 
and demonstrated that each region of the cerebellum displays lower PC density 
in autism, but crus I and II, lobule VIIa of the posterior lobe, display the most 
substantial and consistently lower PC density. This finding is intriguing in light 
of our understanding of VIIa’s evolutionary elaboration in concert with the 
frontal cortex in human evolution (Balsters et al. 2010), its established reciprocal 
connectivity with prefrontal and multimodal association cortices (Xiong et al. 
2002), and demonstrated involvement in executive function, behavioral planning, 
and language processing (Bellebaum and Daum 2007, Schmahmann  2010, 
Tedesco et al. 2011).   
Additionally, Chapter 1 provides preliminary evidence of a sexual 
dimorphism in autism development within the flocculonodular lobe, lobule X.  
In our limited sample, we have observed that lobule X PC density is only lower 
in males.  Lobule X is a component of the archicerebellum and has a well-
established role in the processing of occulomotor and vestibular information 
(Wegiel et al. 2013).  There is also speculation that this region, particular the 
nodulus within the vermis, is capable of regulating limbic function to impact 
emotion, although this requires further exploration.  Our study was the first to 
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find that lobule X PC density is correlated with the ability to appropriately 
employ social and communicative eye contact.   
 
The Cerebellum is a Coordinator of Cognition and Behavior  
The cerebellum’s role in coordinating complex cognitive processes has 
been demonstrated and its involvement in a wide array of behavioral and 
cognitive symptomatology is now gaining the attention of researchers 
(Schmahmann 2010).  The list of non-motor functions believed to be influenced 
by the cerebellum continues to grow, and includes the executive functions of 
working memory (Bellebaum and Daum 2007), multitasking (by regulating the 
automaticity of learned movements) (Lang and Bastian 2002), and behavioral 
inhibition (Rubia et al. 2007).  Indeed, the ability of the cerebellum to integrate 
information from the brain’s sensory and higher multimodal processing regions 
makes the cerebellum perfectly poised anatomically to provide assistance in the 
modification of a behavioral strategy in response to changing environmental 
conditions (which can include social stimuli).   Furthermore, of relevance to 
autism symptomatology, the cerebellum contributes to attention (Townsend et 
al. 1999), linguistic processing (Murdoch 2010), and emotion (Turner et al. 2007, 
Seo et al. 2013).   
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 Sensorimotor Gating, the Distributed Regulation of Stimulus Salience and 
Behavioral Inhibition 
 Sensorimotor gating is a ubiquitous process in the central nervous system, 
and provides clues about not only how an organism expressly responds to its 
environment, but also how different neural circuits respond to each other 
throughout the brain.  In the classic models of sensorimotor gating, researchers 
have focused on the well-characterized startle response, in which a sudden and 
unanticipated startling stimulus (of any modality) is known to generate an 
immediate motor response that is coordinated by pontine nuclei.  Researchers 
discovered long ago that applying a prepulse, or light stimulus application (of 
any modality), approximately 100ms prior to the startling stimulus will result in 
a noticeable inhibition of the startle response (Hoffman and Fleshler 1963, Koch 
1999, Swerdlow et al. 1999).  We have come to know this phenomenon as gating, 
whereby inhibitory neurons dynamically control the threshold for excitability in 
a circuit, an important process to ensure useful information can be filtered from 
background noise in the system.   
 As mentioned above, it has been hypothesized that many individuals with 
autism develop an imbalance between excitation and inhibition at the 
neurochemical level, and further studies have demonstrated this effect at the 
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cellular level as well, which can have important consequences regarding the 
spread of information and its processing (Rippon et al. 2007, Benarroch 2013).  In 
autism, researchers have begun to investigate prepulse inhibition (PPI) and have 
provided preliminary evidence of its disruption in a subset of individuals 
(McAlonan et al. 2002, Yuhas et al. 2011), although further research is needed to 
characterize the sensorimotor gating impairments in individuals with autism.  As 
discussed in detail in Chapter 2, PPI involves a widely distributed network of 
brain regions that are capable of augmenting the excitability of the primary 
startle response circuit.  Along these lines, abnormal startle response 
modification by affective stimuli has been observed in autism (Wilbarger et al. 
2009).   
We sought to explore an animal model of sensorimotor gating disruption 
in which Sprague-Dawley rats were chronically administered dizocilpine to 
block NMDA receptor transmission.  Our collaborators on this project, Levin et 
al. at the Duke Institute for Brain Sciences, have a long history of 
psychopharmacological investigation and research of the PPI phenomenon.  
Clozapine had previously been demonstrated to improve sensorimotor gating 
impairments in humans (Kumari et al. 1999, Vollenweider et al. 2006).  Levin et 
al. demonstrated the ability of clozapine to mimic this therapeutic effect in the 
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dizocilpine rat model of sensorimotor gating impairment (Levin et al. 2007).  As 
discussed in Chapter 2, clozapine’s ability to improve PPI in a variety of rodent 
models as well as in humans has been correlated with its therapeutic potential in 
treating psychiatric symptoms.  As clozapine has a number of protein targets 
throughout the nervous system, it is known to cause undesirable side effects in a 
subset of patients that preclude its long-term utilization as a pharmacologic 
therapy.  We sought to explore one of clozapine’s more promising 
neurotransmitter targets, histaminergic neurotransmission, to determine if the 
H1 receptor antagonist, pyrilamine, was capable of providing similar benefits for 
sensorimotor gating.  Once our collaborators had established that this was 
indeed the case, we received the postmortem rat brain tissue and began 
autoradiographic procedures to measure histaminergic and the closely related 
cholinergic receptor binding in a number of brain regions implicated in the 
distributed network of PPI regulation.  Using this approach, we found that H1 
receptor binding in the anterior cingulate was reduced with pyrilamine 
administration, an effect that correlated with PPI improvement.  Further, we 
found an increase in α7-nicotinic receptor expression in the insular cortex with 
pyrilamine administration that similarly correlated with PPI improvement.  This 
study represents some of the first evidence (outside of preliminary fMRI 
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investigations) to correlate insular and anterior cingulate functions with PPI.  
Chapter 2 explains that both regions are highly implicated in autism 
symptomatology, and current research in our lab is underway to identify 
additional components of this regulatory network that could improve our 
understanding of sensory processing and behavioral inhibition in autism. 
 
Histamine’s Newly Rediscovered Importance in Neuroscience 
The monoamine, histamine, has experienced reconsideration for its role as 
a neurotransmitter in recent years.  In the brain, histamine is solely produced 
within the tuberomamillary nucleus from which it projects to distal regions of 
the brain, including the cerebellum.  It has established roles in regulating 
alertness and is notably expressed on cholinergic neurons.  A number of 
neuropsychiatric illnesses are associated with altered histamine 
neurotransmission.  (For a review of histamine’s newfound roles in neurobiology 
in health and illness: Nuutinen and Panula 2010, Van Ruitenbeek et al. 2010).   
Histamine lies at the interface between the nervous and immune systems, 
yet oddly, it has hardly been explored in this context.  There has been some 
evidence, however, of histamine’s involvement in scenarios entailing more 
severe neuroimmune dysregulation, such as multiple sclerosis and encephalitis 
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(Passani and Ballerini 2012).  Histamine is an initiator of inflammation, and is 
capable of stimulating macrophages (including microglia within the brain), 
lymphocytes, and dendritic cells (Jutel et al. 2006).  In the periphery, histamine is 
commonly associated with mast cell function.  These granulated cells carry 
immunoglobins on their surface and contain large quantities of histamine.  They 
are stimulated to degranulate by a wide variety of stimuli, and are an important 
component in the development of autoimmunity and allergic reactions (Nielsen 
et al. 1992, Schneider et al. 2010).  Despite their well-recognized roll in the 
periphery, mast cells are also an important regulator of blood-brain-barrier 
permeability (Zhuang et al. 1996), which can exacerbate neuroinflammatory 
processes. 
   Researchers have yet to directly assess histamine levels in autism.  
However, it has been demonstrated that neurotensin levels are significantly 
increased in the serum of children with autism, which is a potent and dose-
dependent stimulator of mast cells (Carraway et al. 1982, Theoharides et al. 
2013).  Our study explained in Chapter 3 represents the first to quantify 
histamine receptor levels in the brain in autism.  We did not identify a significant 
difference in histamine H1 receptor expression in lobule VIIa in our preliminary 
investigation, but due to histamine’s involvement in stimulating microglial 
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activation, further exploration of other histamine receptor subtypes in this region 
and histaminergic transmission in other brain regions is merited in future studies 
of autism. 
 
Potential Cerebellar Regulation of Prepulse Inhibition 
 The cerebellum has not been extensively studied in the context of PPI or 
sensorimotor gating.  This is somewhat surprising in light of its established 
connectivity with every aspect of the distributed PPI network.  Figure 1 presents 
a summary of the relationships between the cerebellar regions studied and the 
PPI network components investigated for this dissertation.  The cerebellum is 
highly involved in regulating the gating of a wide variety of reflexes (for a 
detailed review, MacKay and Murphy 1979).  The deep cerebellar nuclei 
innervate the reticular activating system (including the specific components of 
the primary PPI circuit) and the fastigial nucleus is known to exert a strong tonic 
influence on this system (Manzoni et al. 1967).   
 
Biochemical Exploration of Cerebellar Pathology in Lobule VIIa 
 Chapter 3 describes results from a series of western blot assays of 
postmortem frozen samples from crus I & II of lobule VIIa.  Because lobule VIIa 
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demonstrated the most significant alteration in PC density in our autism cases, 
and in light of the preliminary evidence of neuroimmune dysregulation 
described above, we hypothesized that this region would demonstrate evidence 
of gliosis or inflammatory cytokine expression.  Apart from our quantification of 
H1 receptors in lobule VIIa, we performed additional western blots to quantify 
the glial activation markers, IBA-1 and GFAP, which correspond to microglia 
and astroglia, respectively.  We further quantified the expression of IL-6, an 
important neuroimmune regulatory cytokine that was found to be increased in 
the cerebellum in autism in a preliminary study (Wei et al. 2011). 
 An additional focus of our investigations has been the theory that sex 
hormone dysregulation in autism favors androgen signaling over estrogen 
signaling, and further that estrogen-mediated anti-inflammatory and pro-
survival signaling underlies the 4:1 male-to-female ratio of autism’s prevalence.  
Therefore, we quantified estrogen and androgen receptors in lobule VIIa, as well 
as the enzyme, aromatase, which is responsible for the conversion of testosterone 
to estradiol. 
Our data did not confirm prior studies’ findings that these proteins were 
differentially expressed in the cerebellum in autism.  Chapter 3 explains our full 
methodology as well as our rationale for investigating these proteins and 
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suggests future experimental designs to better address the potential involvement 
of the neuroimmune and neuroendocrine systems in the cerebellar 
pathophysiology of autism.   
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Figure 1. Relationships between the presented studies. 
  This image reflects the many relationships in the literature that tie 
together the studies presented in this dissertation.  We have simplified the 
diagram to focus on the systems analyzed within our studies, but the distributed 
network of PPI regulation as well as cerebellar interaction with these systems is 
extensive.  Yellow and orange items represent anatomical regions; blue and 
green items represent proteins analyzed.  The core prepulse inhibition circuit 
within the pontine reticular system is composed of: the primary startle nucleus, 
nucleus reticularis pontis caudalis (PNC), which connects directly to the spinal 
motoneurons required to elicit the startle response; and the regulatory nucleus, 
nucleus tegmentalis pedunculopontinus (PPTg).  Both nuclei have been shown to 
connect to the dentate and fastigial deep cerebellar nuclei.  Further, lobule VII of 
the cerbellum, in which we demonstrated the most significant alterations in PC 
density, sends its projections to these deep nuclei.  To the left in this diagram, we 
display the anterior cingulate and insular cortex, within which we have 
demonstrated a relationship between histamine and acetylcholine receptors and 
PPI of the startle response.  These cortical areas also receive projections from the 
cerebellar deep nuclei.  The many potential pathways mediating the cortical 
regulation of PPI are discussed in Chapter 2.   
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 Histamine’s involvement in cerebellar physiology and in directly 
modulating the excitability of the PPI circuitry has been demonstrated, although 
not explored in detail (Khateb et al. 1990, Palacios et al. 1979, He et al. 2012).  This 
highlights further investigations that are merited to better understand 
histamine’s involvement in sensorimotor gating. 
 References considered in charting the anatomical connections include the 
following: Manzoni et al. 1967, MacKay and Murphy 1979, Noda and Oka 1985, 
Gonzalo-Ruiz and Leichnetz 1987, Brodal and Bjaalie 1997, Ruggiero et al. 1997, 
Bastmeyer et al. 1998, Koch 1999, Muthusamy et al. 2007, Rubia et al. 2007, Habas 
et al. 2009 & 2010, Sugihara 2011, Tykocki et al. 2011, Bernard et al 2012, Sultan et 
al. 2012, Bernard et al. 2013, Bostan et al. 2013, Lynn 2013.  The protein 
interactions depicted in the lobule VII are discussed in detail in Chapter 3. 
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Figure 1 
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CHAPTER 1 
The following manuscript was submitted for publication to PLOS ONE on 
August 1st, 2013: 
 
REGIONAL ALTERATIONS IN PURKINJE CELL DENSITY  
IN PATIENTS WITH AUTISM 
Authors: Jerry Skefos, Christopher Cummings, Katelyn Enzer, Jarrod Holiday, 
Katrina Weed, Ezra Levy, Tarik Yuce, Thomas Kemper, Margaret Bauman 
 
Abstract 
Neuropathological studies, using a variety of techniques, have reported a 
decrease in Purkinje cell (PC) density in the cerebellum in autism.  We have used 
a systematic sampling technique that significantly reduces experimenter bias and 
variance to estimate PC densities in the postmortem brains of eight clinically 
well-documented individuals with autism, and eight age- and gender-matched 
controls.  Four cerebellar regions were analyzed: a sensorimotor area comprised 
of hemispheric lobules IV-VI, crus I & II of the posterior lobe, and lobule X of the 
flocculonodular lobe.  Overall PC density was thus estimated using data from all 
three cerebellar lobes and was found to be lower in the cases with autism as 
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compared to controls, an effect that was most prominent in crus I and II (p < 
0.05).  Lobule X demonstrated a trend towards lower PC density in only the 
males with autism (p = 0.05).  Brain weight, a correlate of tissue volume, was 
found to significantly contribute to the lower lobule X PC density observed in 
males with autism, but not to the finding of lower PC density in crus I & II.  
Therefore, lower crus I & II PC density in autism is more likely due to a lower 
number of PCs.  The PC density in lobule X was found to correlate with the ADI-
R measure of the patient’s use of social eye contact (R2 = -0.75, p = 0.012).  These 
findings support the hypothesis that abnormal PC density may contribute to 
selected clinical features of the autism phenotype.  
 
Introduction 
Autism is a behaviorally defined neurodevelopmental disorder with core 
symptoms of impaired social interaction, delayed development of and 
qualitative abnormalities in communication, and restricted/repetitive and 
stereotyped behavior patterns (American Psychiatric Association, 1994).  Its wide 
range of additional associated symptoms and comorbidities has complicated 
efforts to determine the core neuropathological features of autism.  Despite this 
clinical heterogeneity, numerous studies have described abnormalities involving 
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the cerebellar circuitry and the limbic system (Amaral et al. 2008).  Within the 
cerebellum, the consistently widely reported finding has been a decrease in the 
density of the Purkinje cells (PCs) (Williams et al. 1980, Ritvo et al. 1986, Fehlow 
et al. 1993, Kemper and Bauman 1993, Bailey et al. 1998, Lee et al. 2002, Vargas et 
al. 2005, Whitney et al. 2008), the large projection neurons in the cerebellar cortex.  
This is the first study, however, that was designed to precisely quantify regional 
alterations in PC density in autism and to test for association between PC density 
and a selection of relevant clinical behavioral measures. 
In the present study, using a stereologic technique, we determined the PC 
densities in four cerebellar regions (Fig. 2).  Two of these regions, crus I and II in 
the posterior lobe, were selected because previous studies have frequently noted 
abnormalities in these areas (Ritvo et al. 1986, Kemepr and Bauman 1993, Bailey 
et al. 1998, Lee et al. 2002, Vargas et al. 2005, Whitney et al. 2008).  Crus I and II 
are known to reciprocally connect with prefrontal cortical networks that 
modulate social behavior and behavioral planning (Ito 2008, Schmahmann 2010).  
The third region, lobule X (the flocculonodular lobe), is associated with eye 
movement as well as vestibular regulation (Brauth 1977, Schmahmann 1996, 
Cohen et al. 1999, Balaban 2004, Straka et al. 2006, Pakan et al. 2010) and has been 
previously reported to display pathology in a subset of postmortem autistic cases 
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(Bauman and Kemper 2005), some of which were included in the present study 
(Wegiel et al. 2010, Wegiel et al. 2013).  The fourth region, the hemispheric 
portion of lobules IV-VI, is a primary sensorimotor processing area that has been 
reported to undergo an age-dependent decline in PC density (Andersen et al. 
2003, Ito 2012, Stoodley et al. 2012).    
In an attempt to improve upon previous studies of PC density in autism, 
we sampled from a series of sections obtained throughout the entire cerebellum 
to measure PC density in regions within each of the three cerebellar lobes.  In 
addition, the stereological methodology employed in this study significantly 
reduced the potential for variance in data acquisition due to subjective 
determinations, as compared with prior attempts to quantify PCs in autism 
(Williams et al. 1980, Ritvo et al. 1986, Fehlow et al. 1993, Kemper and Bauman 
1993, Guerin et al. 1996, Bailey et al. 1998, Fatemi et al. 2002,  Lee et al. 2002, 
Vargas et al. 2005, Whitney et al. 2008).  With this methodology, we have attained 
a strong inter-rater reliability (>95% concurrence between the measurements of 
seven stereologists) and low variance in the data.   Furthermore, the cases we 
have included in the autism group were selected to approximate the incidence of 
mental retardation (MR) and epilepsy in the overall autism population, which 
was not a feature of prior investigations, disallowing an assessment of the 
28 
contribution of MR and epilepsy to the observation of lower PC density in 
autism in these studies (Danielsson et al. 2005, Centers for Disease Control and 
Prevention 2009). 
Methods 
Case Demographics 
The cerebella were obtained from the postmortem brains of eight 
individuals with autism and eight gender- and age-matched controls.  Six of the 
cases were females (age range 4 to 21 years) and ten were males (age range 7 to 
56 years), thus each group had 3 females and 5 males.  All individuals in the 
autism group met DSM-IV and ADI-R criteria for autism spectrum disorders 
(American Psychiatric Association 1994, Lord et al. 1994).  The control cases had 
no known neurological disorder or known neuropathology.  The clinical 
characteristics of both groups are summarized in Table 1.  Postmortem interval 
(PMI), or time before initiating brain preservation, did not significantly differ 
between males and females nor between the autism and control groups.  The 
majority of cerebella were sampled from the right hemisphere (88%), (Table 1).  
Three cases in the autism group were diagnosed with MR (IQ < 70), ranging from 
mild to severe.  Other symptoms in the autism group included: complications 
during pregnancy (38%), epilepsy (38%), delayed motor milestones (50%), 
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delayed acquisition of verbal communication skills (88%), emotional 
disturbances such as depression and aggression (50%), and difficulty 
coordinating gaze (38%). Three cases in the autism group were reported to have 
suffered from developmental regression, two of whom had documented 
epilepsy.  ADI-R scores did not significantly differ between males and females, 
but the male cases represented a wider age range (t = 2.35, df = 14, p = 0.036) than 
the female cases. The difference in average brain weight between males and 
females in our autism group was approximately twice the calculated difference 
for all autism cases cataloged in the Autism Tissue Program (ATP) database (327 
vs. 186 grams) [http://www.atpportal.org], which may be a reflection of the small 
sample size available for this study.  Based on the ATP data, cases diagnosed 
with autism display similar male-to-female differences in brain weight as 
controls, which is approximately a 10% increased fresh brain weight in males 
(Dekaban 1978).  Due to this divergence from the normative data (in which we 
noticed an approximate 20% difference in our samples between the male and 
female autism cases), we have tested our analyses of PC density for covariance 
with brain weight and cerebellar volume (as described below in Statistical 
Analyses). 
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Tissue Preparation 
This study utilized prepared cerebellar histological sections obtained from 
the ATP. These sections are a component of the ATP’s Brain Atlas Project, which 
is a multi-site collaborative investigation of an established cohort of identically 
processed cases that agreed to donate their brain tissue for autism research 
(http://www.autismtissueprogram.org). 
Tissue prepared for the Brain Atlas Project was processed by the New 
York State Institute for Basic Research in Developmental Disabilities (NYS-IBR) 
following protocols approved by their Institutional Review Board (Wegiel 2010).  
Whole fresh brain weights were obtained prior to processing.  Each brain was cut 
mid-sagittally through the corpus callosum and brainstem.  One brain 
hemisphere was fixed in 10% buffered formalin, and the other brain hemisphere 
was frozen.  Following at least 3 weeks of fixation, MRI scans were acquired of 
the fixed brain hemispheres from the cases in the autism group using a 1.5 T GE 
Signa Imager (General Electric, Milwaukee, USA).  T1-weighted, fast gradient 
echo MRI was used to sample each brain in 1.5 mm-thick virtual slices in the 
coronal plane, perpendicular to the anteroposterior axis of the hippocampus 
(FOV = 25cm, NEX = 1, matrix = 256 x 192, TR = 35ms, FA = 60°).  Following 
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imaging, each fixed hemisphere was washed overnight in water and 
subsequently dehydrated in increasing ethanol concentrations (50% for 3 days, 
70% for 4 days, 80% for 3 days, and 95% for 4 days).  The tissue was then 
embedded in 8% celloidin (Heinsen et al. 2000).  Celloidin blocks were hardened 
in chloroform vapor for approximately 2.5 weeks, and then stored in 70% 
ethanol.  A series of serial 200 µm sections separated by 1.2 mm increments 
(every 6th section) was obtained throughout the entire brain hemisphere as well 
as through the brainstem and cerebellum of each case (Fig 3a).  The sections were 
immersed in water for 2-3 hours, after which they were Nissl-stained with cresyl 
violet and mounted with Acrytol.  Each case was assigned a brain bank 
identification number to maintain donor anonymity. 
 
Stereological Methodology 
Using two cerebellar atlases (Angevine et al. 1961, Schmahmann 2000), the 
cerebellar regions were anatomically defined as follows: crus I is bordered by the 
superior posterior and horizontal fissures; crus II is bordered by the horizontal 
and ansoparamedian fissures; lobule X includes the nodulus and flocculus which 
together are bordered by the posterolateral fissure; and hemispheric lobules IV-
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VI are bordered by the preculminate and superior posterior fissures, lateral to the 
fourth ventricle (Fig. 2).   
To facilitate unbiased quantification of PCs within each selected cerebellar 
region, the optical disector probe (Gundersen et al. 1988), a 3D counting frame, 
was employed throughout the entire series of cerebellar slides (approximately 40 
slides per case), such that we sampled throughout the entirety of each region of 
interest (Fig. 3).  Each cerebellar lobule was sampled throughout the cortex and 
adjacent white matter (Fig. 3b).  Slides were analyzed using a Nikon Eclipse 80i 
microscope equipped with a motorized stage (Ludl Electronic Products, 
Hawthorne, NY) and microcator (a positional deviation meter, Heidenhain, 
Schaumburg, IL) for precise navigation in the XY and Z planes of the section, 
respectively.  The microscope was guided by a computer with the 
Stereoinvestigator 10 (MBF Bioscience, Williston, VT) software package 
calibrated to move the slide with 1µm precision.  This system ensured 
systematic, uniform and random sampling.  Preliminary measures were taken to 
ensure >95% inter-rater reliability (number of stereologists = 7) and <0.07 
coefficient of error (CE) for each region investigated (Gundersen CE, m=1. For a 
detailed description: Gundersen et al. 1999).  Our counting object was the PC 
soma, which was readily identifiable with a 40X objective lens (NA=0.75), and 
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thus PCs were counted when the borders of the soma were in focus.  Slides were 
viewed through the microscope eyepiece as well as on the computer monitor 
using an Optronics Microfire digital camera.  The ATP Brain Atlas celloidin 
series is comprised of 200µm sections designed to aid in volumetric analyses. 
However, PCs were most reliably identifiable through a depth of the first 80µm 
in each section due to excessive light diffraction at greater depths.  Therefore, we 
employed a 5µm guard volume (to prevent counting error due to cell loss during 
tissue sectioning) and sampled through 75µm below the guard volume.  The 
computer software ensured that the 19,600µm2 counting frames were randomly 
imposed and evenly spaced within the region of interest on each slide (Fig. 3c).  
The distance between the counting frames was determined separately for each 
cerebellar region to ensure that optimal sampling parameters were employed.  
Sampling parameters were considered optimal if they minimized systematic 
error from oversampling, while still providing reliably reproducible estimates of 
PC density, as determined by the CE (Mouton et al. 2002).  Using optimized 
parameters, a counting frame was placed every 2500µm2, 2200µm2, 400µm2, and 
1400µm2 along the X and Y axes, in crus I, crus II, lobule X, and hemispheric 
lobules IV-VI, respectively.  As a result, the mean number of counting frames for 
each of these four regions was: 1106, 818, 1392, and 1690, respectively.  Overall, 
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approximately 5,000 counting sites throughout the three cytoarchitectonic layers 
of the cortex and the associated underlying white matter were assayed in each 
cerebellum (Fig 3).  Using these parameters, approximately 450 PCs were 
counted in each cerebellar region with an average CE of 0.053.   
In some cases, less than 100% of each region of interest was available, 
which precluded the possibility of obtaining estimates of total PC number.  Case 
notes indicated that as much as 10% of the tissue had been lost during 
processing.  In addition, some slices demonstrated fraying at the edge of the 
folia.  In a few instances, these complications prevented us from obtaining 
estimates from each target region and thus only the regions that could be 
completely sampled were analyzed.  As a result, rather than estimating total PC 
number, data were analyzed as PC density measurements, calculated by dividing 
the total number of PCs counted in a region by the summed volume of each 
counting box placed in that region (Eq. 1). 
Equation 1 
sampled
PC
PC Volume
NumberDensity =  
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Additional Volumetry Using MRI 
We were able to collect a measure of total cerebellar volume for each case 
in the autism group by performing planimetry on the MRI data obtained by the 
NYS-IBR using the formalin fixed brains.  Tissue shrinkage during fixation 
ranged from 44% to 52% and did not differ significantly between the autism and 
control groups.  Planimetry was performed with ImageJ 
[http://rsbweb.nih.gov/ij/] using the Yawi3D plugin 
[http://yawi3d.sourceforge.net], which generates an automated selection of the 
region of interest on each MRI slice.  Following manual adjustment using a pen 
tablet interface (Wacom, Otone, Japan) to ensure precise delineation of cerebellar 
boundaries, the cerebellar area in each slice was calculated and summed.  As the 
MRI acquisition and tissue processing protocols used in this study were 
standardized across samples, it was possible to make comparisons within the 
autism group using the planimetric data for each case.  However, since control 
brains in the Brain Atlas Project lacked MRI data, group comparisons were not 
made.  Obtaining total cerebellar volume measurements for the cases in the 
autism group allowed for an assessment of the contribution of overall tissue 
volume to PC density in each region, particularly as it pertained to gender 
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differences within the autism group, as well as the correlation between PC 
density and behavioral measures. 
 
Statistical Analyses 
To assess the differences between group means on the basis of gender and 
autism diagnosis, we performed a linear mixed model test fitted by maximum 
likelihood, with weighted least squares (WLS) correction based on the regional 
volume from which each PC density measure was obtained.  To test for regional 
differences in PC density as an effect of gender and autism diagnosis, we 
repeated the test without the WLS correction.  The above tests were also repeated 
with brain weight as a covariate to investigate the contribution of brain weight to 
our findings (Table 2).  False discovery rate controlled t-tests (Curran-Everett 
2000) were then performed to inspect the interaction between gender, diagnosis, 
and region.  The appropriate t-test was chosen based on the results of Levene’s 
test of equality of variances between each group.  PC density measures in each 
region were tested for correlation with the non-parametric scores in each domain 
of the ADI-R (communication, social interaction, and restricted/repetitive 
behavior), as well as with the 7 specific questions in the ADI-R recently identified 
by machine learning analyses to be most indicative of an autism diagnosis 
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[Presentation by Dennis Wall, “Shortening the Behavioral Diagnosis of Autism 
Through Artificial Intelligence and Mobile Health Technologies,” Autism 
Consortium 2011 Symposium, Boston, MA].  (For a detailed description of the 
statistical methods used to select these specific behavioral variables, Wall et al. 
has recently published a similar analysis of the Autism Diagnostic Observation 
Schedule: Wall et al. 2012).  For all tests of correlation involving non-parametric 
behavioral measures, Spearman rank correlations were performed.  To assess the 
probability of a false positive correlation, the false discovery rate procedure was 
performed.  The effects of potentially confounding factors or clinically relevant 
covariables were investigated.  Parametric variables such as age, brain weight, 
cerebellar volume, PMI, and fixation time were tested for covariance with PC 
density estimates using univariate generalized linear models.  To test the effects 
of clinically relevant factors reported in the case histories of the autism group, 
such as epilepsy, diagnosis of MR, developmental regression, lack of verbal 
development, delay in attaining motor milestones, and complications during 
pregnancy, separate t-tests were performed for each cerebellar region.  
Additionally, for cases in the autism group, linear regression analysis was 
performed to detect potential associations between PC density and the age at 
which the subject first walked unaided.   
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Logarithmic transformation was performed on all PC density estimates to 
adjust for skew from a normal distribution.  The significance of each finding was 
only marginally affected by this transformation.  Because our PC measures were 
obtained from each lobe of the cerebellum (anterior, posterior, and 
flocculonodular), we generated an estimate of overall cerebellar PC density as a 
composite of the regional volume-weighted mean PC densities.  Therefore, PC 
density estimates from larger cerebellar regions (crus I & II) had a greater impact 
on this overall PC density estimate (similar to the WLS correction in the linear 
mixed models described above).  Cerebellar regional volumes used in this overall 
PC density estimate were based on planimetric measurements obtained from the 
histological sections during stereological PC density estimation.   
All statistical tests were two-sided, with an alpha level of 0.05, and false 
discovery rate was used to adjust the cutoff for significance as mentioned in the 
Results.  Confidence intervals were set at 95% for all comparisons, and for 
correlations, these intervals were determined using bootstrapping with 1,000 
replications.  Statistical computations were performed with SPSS Version 19 
(IBM, Armonk, NY). 
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Results 
Comparisons Based on Diagnosis 
1. Autism cases demonstrate a lower overall Purkinje cell density. 
We pooled all PC density measurements for each case and tested for an 
overall difference in PC density based on autism diagnosis using a linear mixed 
model.  The model clustered the PC density measures from each case, and 
weighted the significance of each region’s PC density measures in proportion to 
the respective region’s volume (thereby avoiding the overrepresentation of 
smaller regions in the overall analysis).  The regional volume estimates utilized 
in this analysis were calculated from histological area measurements of each 
region obtained as the PCs were quantified on each slide. 
Utilizing this model, we observed an effect of autism diagnosis on overall 
PC density (p = 0.02, Table 2, Test 1).  This was reflected as an 11% lower regional 
volume-weighted mean PC density in the autism group.  This finding was 
additionally corrected for covariance with each case’s brain weight, which only 
slightly improved the significance (p = 0.01, Table 2, Test 2).  Because brain 
weight is a correlate of brain volume (Witelson et al. 2006), this finding indicates 
that the difference in PC density between the autism and control groups may not 
be due to volumetric differences but may rather reflect a difference in overall PC 
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number.  An alternative possibility is that regional volumetric changes occur in 
autism (that may not make a substantial impact on overall brain weight but 
could still affect regional PC density), but a linear mixed model designed to test 
this found no effect of diagnosis on regional volume (p = 0.936). 
 
2. Purkinje cell density is more affected in crus I & II in autism. 
Linear mixed models were used to test for an interaction between autism 
diagnosis and regional PC density (Table 2, Tests 3 & 4).  These tests indicated 
that autism did not affect any of the four regions’ PC densities differentially (p = 
0.768, Table 2, Test 3).  Indeed, each region demonstrated a lower PC density in 
the autism cases compared to controls.  Furthermore, we found that the densities 
of some of the regions were highly correlated: crus I & II exhibited the strongest 
correlation (R2 = 0.832, p = 1.2x10-4).  When the effect of gender was incorporated, 
however, we did observe a three-way interaction between gender, diagnosis, and 
region (p = 0.014, Table 2, Test 3).  This indicates that autism affects each region 
differently in males compared to females.  Figure 4 demonstrates these regional 
effects, and shows that in crus I & II, both males and females displayed a lower 
PC density in the autism group. 
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Our a priori hypothesis based on previous studies was that PC density 
would be most affected in crus I & II in autism (Ritvo et al. 1986, Kemper and 
Bauman 1993, Bailey et al. 1998, Lee et al. 2002, Vargas et al. 2005, Whitney et al. 
2008).  To investigate this, we proceeded with post hoc analyses of each region’s 
PC density with respect to autism diagnosis using t-tests controlled for false 
discovery rate.  These tests demonstrated that the major effect of autism 
diagnosis on PC density was in crus I & II, which demonstrated an 
approximately 20% lower PC density (p = 0.039 & p = 0.032, Fig. 4, Table 3). 
 
3. Age-related decline in Purkinje cell density does not differ in autism. 
Prior investigations have reported evidence of an age-related decline in 
PC density in the anterior lobe (Andersen et al. 2003).  Our PC density measures 
from the hemispheric portions of lobules IV-VI displayed a trend in support of 
these previous observations that did not reach significance (R2 = -0.23±0.16, p = 
0.097).  However, the age range of our samples did not extend as far into old age 
as in the prior reports.  If samples from individuals with more advanced age 
were included in the present investigation, it is possible we would have observed 
a more significant correlation between age and PC density in this region.  
Nonetheless, we did observe an age-related decline in overall PC density (R2 = -
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0.39 ±0.14, p = 0.030, Fig. 5) that did not differ between the autism and control 
groups. 
 
4. Flocculonodular dysplasia does not impact PC density. 
All of the cases in our autism group have been analyzed by 
neuropathologists at the NYS-IBR in a manner that was blind to diagnosis.  Five 
cases in our study (63%) were reported to display flocculonodular dysplasia by 
Wegiel et al. (2010).  However, we found that lobule X dysmorphology had no 
effect on the PC density in this region (p = 0.662). 
 
Comparisons Based on Gender 
1. Males have a lower overall Purkinje cell density than females. 
We investigated the effect of gender on overall PC density by using the 
same linear mixed model discussed above (Table 2, Test 1 & 2).  Again, this test 
incorporated all PC density measures, clustered by case, and the significance of 
each measure was weighted by the volume of the region from which it was 
taken.  Using this approach, we observed an effect of gender on overall PC 
density (p = 0.036, Table 2, Test 1).  This was reflected as a 21% lower regional 
volume-weighted mean PC density in the male cases compared to the females. 
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It was particularly important to correct this model for covariance with 
brain weight (Table 2, Test 2), because our female cases demonstrated a 13.5% 
lower brain weight than the male cases (t = 2.857, df = 13, p = 0.013).  Doing so 
negatively impacted the significance of gender’s effect on PC density (p = 0.068, 
Table 2, Test 2).  However, one control male case was missing brain weight data, 
and by removing that case from Test 1, we were able to determine that the main 
difference in the significance between Test 1 and 2 was due to a loss of statistical 
power rather than an effect of brain weight on PC density.  (Indeed, excluding 
this case from Test 1 resulted in a similar effect of gender, p = 0.061).  Therefore, 
it appears that volumetric differences minimally contributed to the effect of 
gender on overall PC density in this investigation. 
 
2. Lobule X is more affected in males with autism than females. 
From our linear mixed models descried above (Table 2, Tests 3 & 4), it was 
apparent that not all regions had similar PC densities.  We further confirmed this 
phenomenon with an ANOVA (p = 1x10-4) using Tukey’s HSD post hoc analysis 
and found that lobule X differed from the other regions in terms of PC density, 
most substantially from crus I & II (p < 0.001) and to a lesser extent from 
hemispheric lobules IV-VI (p = 0.036). 
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As demonstrated in Figure 4, we observed that males in the autism group 
had a lower PC density in lobule X while females’ lobule X PC densities 
appeared to be unaffected by autism.  We hypothesized this to be a crucial 
component of the three-way interaction between diagnosis, gender, and region 
identified in the linear mixed models (Table 2, Tests 3 & 4).  We further analyzed 
this phenomenon by performing t-tests comparing the lobule X PC density in 
males and females in our autism and control groups.  This approach 
demonstrated that males in the autism group had a 31.5% lower PC density than 
females in the autism group (t = 3.154, df = 6, p = 0.02), while there was no 
difference based on gender in the control group (p = 0.768).  Additionally, males 
in the autism group had a trend towards a 26% lower PC density than control 
males (t = 2.312, df = 8, p = 0.05), while there was no difference between the 
females in the autism and control groups (p = 0.921).  We must emphasize that 
this is a highly preliminary finding because of the low sample size, particularly 
with respect to female cases.  Indeed, applying a univariate generalized linear 
model to test for the interaction between gender and diagnosis in affecting lobule 
X PC density did not prove significant (p = 0.193).  The observed power for this 
analysis was 0.24 and the effect size f was 0.36.  This is a medium-sized gender 
by diagnosis interaction effect that would require a larger sample pool to reach 
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significance.  Further research is required to determine if this finding is 
reproducible in a larger study, as it may represent a unique gender-based 
difference in the neuropathology of autism. 
We further assessed the contribution of age to our preliminary finding of a 
gender-based disparity in lobule X PC density in the autism group, because the 
females in our study were younger than the males (t = 2.35, df = 14, p = 0.036).  
Using generalized linear modeling with age as a covariate, we found that age 
only marginally affected the significance of this finding (F = 6.881, p = 0.047). 
Volumetric differences may account for the observed gender difference in 
lobule X Purkinje cell density. 
The disparity between male and female brain weights in our autism group 
was nearly twice the expected difference (327 grams compared to 186 grams for 
the autism cases cataloged in the ATP database) [http://www.atpportal.org], 
which may be a reflection of the small sample size available for this study.  
Furthermore, PC density in lobule X was correlated with brain weight in the 
autism group (R2 = -0.67, p = 0.014).  Brain weight is a correlate of brain volume 
(Witelson et al. 2006), and thus we performed a generalized linear model with 
brain weight as a covariate to assess its contribution to the observed gender 
difference in lobule X PC density.  Indeed, eliminating the effect of brain weight 
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impacted the significance of the difference between male and female lobule X PC 
density in the autism group (p = 0.642), as well as the difference between males 
with autism compared to control males (p = 0.117). 
Additionally, MRI data was available for the autism cases in our study 
and we used these to obtain cerebellar volume measurements.  Similar to what 
we observed with brain weight, lobule X PC density in the autism group strongly 
correlated with cerebellar volume (R2 = -0.80±0.02, p = 0.008).  After correcting the 
generalized linear model for covariance with cerebellar volume, we saw a similar 
loss of significance in the difference between male and female lobule X PC 
density in the autism group (p = 0.730). 
In light of these findings, a gender-based disparity in lobule X volume 
likely contributes to the PC density differences observed in this region.  This is in 
contrast to the findings of reduced PC density in crus I & II in autism, for which 
there was no observed difference in the significance following a correction for 
brain weight (p = 0.025 and p = 0.017).  We also noticed in our linear mixed 
model that including brain weight as a covariate marginally increased the 
significance of the three-way interaction between gender, diagnosis, and region 
(p = 0.005, Table 2, Test 4).  Therefore, this volumetric contribution to the PC 
density differences observed in the autism group is limited to lobule X. 
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Behavioral Correlation with Purkinje cell Density 
We examined our PC density estimates looking for possible correlations 
with behavioral measures obtained from the ADI-R.  The ADI-R is comprised of 
93 questions scored on an ordinal scale, which are combined into domain scores 
for the three core autism symptom domains (communication, social interaction, 
and restricted/repetitive behavior).  However, these domain scores compound 
the intrinsic inter-rater variance of each ADI-R question, thus diminishing the 
power to determine relationships between neuropathological findings and 
specific behavioral symptoms.  Therefore, we performed regression analysis on a 
selection of 7 specific ADI-R questions that were recently reported to associate 
strongly with autism diagnosis [Presentation by Dennis Wall, “Shortening the 
Behavioral Diagnosis of Autism Through Artificial Intelligence and Mobile 
Health Technologies,” Autism Consortium 2011 Symposium, Boston, MA].  We 
limited our regression analyses to these specific behavioral variables and 
performed false discovery rate analysis (as detailed in: Curran-Everet 2000) to 
reduce the probability of a type I statistical error. 
 In our initial analysis of ADI-R domain scores, we did not observe a 
significant association between PC density and any of the domain scores.  
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However, in our analysis of specific questions from the ADI-R, we did identify a 
plausible association between lobule X PC density and social/communicative use 
of direct eye gaze (R2 = -0.75 ±0.04, p = 0.012, Fig. 6).  Utilizing false discovery rate 
analysis, this association failed to meet the cutoff for significance (which was p = 
0.009); however, due to known involvement of this region in regulating eye 
movement (Wegiel 2013), we feel this observation merits further investigation. 
As we had done above, we utilized generalized linear models with brain 
weight or cerebellar volume as a covariate to determine if tissue volume 
contributed to the observed association between lobule X PC density and direct 
eye gaze.  Both of these covariables were found to substantially reduce the 
significance of the association (p = 0.072 for brain weight and p = 0.171 for 
cerebellar volume).  Therefore, tissue volume represents a significant component 
of the observed association between lobule X PC density and the social and 
communicative use of direct gaze. 
 
Analyses of Clinical Covariables and Potential Confounding Factors 
Potential confounding factors and clinically relevant covariables such as 
cerebellar hemisphere, PMI, postmortem fixation time, epilepsy, MR, 
developmental regression, lack of verbal development, delayed attainment of 
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motor milestones, and complications during pregnancy were tested to determine 
their effects on PC density in crus I & II or lobule X, and none were found to have 
a significant effect.  Similarly, none of these factors were found to impact the 
association between lobule X PC density and direct gaze. 
 
Discussion 
Case Demographics 
Cerebellar pathology was first proposed as a potential contributor to 
autism symptomatology in 1968 (Ornitz and Ritvo 1968), and the first qualitative 
report of lower PC density was published in 1980 (Williams et al. 1980).  To date, 
PC density assessments have been reported from 45 cerebella of individuals with 
autism, 30 of which demonstrated a lower PC density, most prominently 
reported in the posterolateral hemispheres where crus I & II are located 
(Williams et al. 1980, Ritvo et al. 1986, Fehlow et al. 1993, Kemper and Bauman 
1993, Guerin et al. 1996, Bailey et al. 1998, Fatemi et al. 2002, Lee et al. 2002, 
Vargas et al. 2005, Whitney et al. 2008).  Apart from the most recent studies, these 
reports have been criticized as being semi-quantitative at best, and the sample 
selection has not been representative of the demographics of the overall autism 
population as currently defined.  For example, 87.5% of cases analyzed in prior 
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reports (for which data is available) exhibited MR compared with the recently 
reported 41% in the autism population (Centers for Disease Control 2009), and 
57.9% of these cases exhibited epilepsy compared with the recent estimate of 38% 
in the autism population (Danielsson et al. 2005).  Furthermore, only 6 cases were 
females, despite the estimated 4.5:1 male-to-female ratio of autism’s prevalence 
(Centers for Disease Control 2009).  This has prevented gender-based 
comparisons of autism neuropathology in the past.  For this study, we included 3 
female cases with autism and 3 female controls as a preliminary assessment of 
the effect of gender on PC density in autism.  It is difficult to rule out the 
contribution of factors such as epilepsy or MR to lower PC density based on the 
data from prior neuropathological investigations of autism.  The current study 
was thus designed with a sample population more representative of the overall 
autism population, with 38% of samples obtained from subjects with MR ranging 
from mild to severe, and 38% of samples having documented epilepsy. 
 
Stereological Estimation of Purkinje cell Density 
The determination of PC density in the cerebellum is challenging, 
primarily due to complications in defining the anatomical boundaries of the PC 
layer and selecting a reference volume.  A traditional approach has been to 
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quantify PC density by drawing a line through the PC layer and counting the 
number of PC per unit length.  Past studies using this approach have shown 
markedly variable density estimates in healthy controls from as little as 1.6 
PC/mm to as many as 11 PC/mm (Lohr and Jeste 1986, Torvik et al. 1986, Phillips 
et al. 1987, Kume et al. 1991, Karhunen et al. 1994, Fukutani et al. 1996, 
Matsumoto et al. 1998, Wegiel et al. 1999, Sjöbeck and Englund 2001).  An 
inherent problem in placement of this line within the PC layer is the large 
number of subjective determinations.  Factors contributing to this subjectivity 
include: the variable horizontal position of the PCs within this layer, the 
markedly convoluted folding of the layer through which the stereologist must 
draw a curved line, the difficulty in determining the layer’s anatomical 
boundaries at sites where the PCs are sparse or absent, and the changing width 
of the layer as viewed on obliquely cut sections (Fig. 7, 8).  These considerations, 
along with the very narrow width of the human PC layer (1 to 2% of the width of 
a cerebellar folium), create problems for the accurate measurement of the PC 
layer volume and thus for its use as a reference volume to measure the density of 
PCs. 
In order to obviate these issues and provide a more reliable estimate of PC 
density, we sampled from the entirety of each region of interest, within clear 
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anatomical boundaries, and thus included the subcortical white matter of each 
region.  With this strategy we were able to eliminate over 50% of the variability 
in our PC density estimates (compare to: Whitney et al. 2008).  Further, our 
measurements of PC/mm3 closely agree with recently published estimates 
obtained using a novel stereological probe designed to better assess the density 
of objects like PCs that are distributed within a limited and convoluted portion of 
the region of interest (Agashiwala et al. 2008). 
Neuronal density is an important morphometric measure in 
neuropathology, despite the inherent variability that occurs as a consequence of 
differential tissue shrinkage in each case.  In this study, tissue shrinkage resulting 
from tissue processing varied only marginally from 44% to 52% according to the 
pathologists’ reports and did not differ between groups.  An alternative 
stereological strategy is to quantify total neuronal number using the Optical 
Fractionator probe, but this requires 100% of the assayed region to be pristinely 
represented in the sampled slides (Gundersen et al. 1988).  Neuronal density 
measures are distinct from estimates of total number however, in that they reflect 
the spacing of neuronal somas and neuropil in a tissue, a property that has a 
number of physiological implications (Cullen et al. 2010, Ivenshitz and Segal 
2010).   
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Implications of Cerebellar Neuropathology in Autism 
The results of the present investigation corroborate prior reports of lower 
PC density in autism, and using a more precise and thorough method of 
quantification, demonstrate that lower PC density is most prominent in crus I 
and II, which constitute lobule VIIa of the posterior lobe.  Lobule VIIa is 
intimately involved with numerous neocortical areas and has been directly 
implicated in non-motor functions in humans.  In a report of 156 patients with 
cerebellar damage, 100% of patients with crus I lesions presented with attention 
impairments, and 100% of patients with crus II lesions presented with 
impairments in visuospatial memory and verbal memory (with some overlap 
between the two regions’ functions) (Tedesco 2011).  Further, a recent fMRI study 
demonstrated involvement of lobule VII in auditory working memory in 
nonhuman primates (Hayter et al. 2007).  Anatomical and comparative 
anatomical studies have demonstrated a strong relationship between lobule VII 
and the cerebral cortex.  Comparative studies highlight a relationship between 
the volume of the prefrontal cortex and that of lobule VII, with a pronounced 
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elaboration of VIIa in human evolution in concert with frontal cortical expansion 
(Balsters et al. 2010).  Lobule VIIa is reciprocally connected with the prefrontal 
cortex, an executive function/working memory area, as well as the posterior 
parietal cortex, a multimodal processing area (Schmahmann and Pandya 1997, 
Xiong et al. 2002, Schmahmann 2010).  Recent studies employing resting state 
fMRI have further demonstrated functional connectivity between lobule VIIa and 
these cortical areas (Habas et al. 2009, O’Reilly et al. 2010).  These prefrontal and 
posterior parietal cortices comprise a Frontoparietal Attention Network (FAN), 
which is postulated to play an important role in processing the salience of 
environmental cues (Ptak 2011).  The prefrontal cortex is involved in a variety of 
working memory and executive functions that have shown impairment in 
individuals with autism (Christ et al. 2011, Holdnack et al. 2011, Yerys et al. 2011, 
Taylor et al. 2012).  Further, it is important to note that in normal brain 
development, lobule VII displays unique features that distinguish it from other 
cerebellar lobules (Altman et al. 1996, Ozol et al. 1999, Rogers et al. 1999, Vastagh 
et al. 2005).  An example of the distinct developmental trajectory of lobule VII 
neurons was demonstrated in a mouse model of immune activation at mid-
gestation, in which a specific reduction in PC density in lobule VII was observed 
but neighboring regions were unaffected (Shi et al. 2009). 
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We have also identified a potential sexually dimorphic effect within lobule 
X.  Lobule X has been associated with vestibular regulation as well as 
coordination of gaze (Brauth 1977, Schmahmann 1996, Cohen et al. 1999, Balaban 
2004, Straka et al. 2006, Pakan et al. 2010).  The lobule X PC density was found to 
be lower in males with autism as a result of increased tissue volume (Fig. 4).  
Furthermore, this effect appeared to correlate with the ability to properly employ 
social and communicative use of eye gaze, as assessed by the ADI-R (Fig. 6).  
This correlation between lobule X PC density and social eye gaze failed to reach 
the cutoff for significance imposed by false discovery rate analysis, but in light of 
the role of lobule X in modulating eye movement, the association is plausible 
(Wegiel et al. 2013).  These preliminary findings will require further investigation 
as this is the first report of the association between lobule X PC density and the 
social employment of eye contact.  Further, we recommend that future 
investigations analyze the flocculus and nodulus within lobule X separately, as 
these regions have functional distinctions (Pakan et al. 2008) and may display 
different pathologies. 
The mechanism of the alterations in PC density noted in this study 
remains unexplained.  As the cerebellum develops in close coordination with 
many other networks within the central nervous system (Larsell et al. 1941, 
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Limperopoulos et al. 2005, Araujo et al. 2007, Rubia et al. 2007, Herculano-
Houzel 2010), it is possible that altered PC density represents a compensatory 
mechanism or downstream effect of an earlier developmental pathology.  In the 
present study, the degree to which PC density diminished with age did not differ 
between the autism and control groups over the age span studied (from 4 to 56 
years).  This lack of a notable age-related decline in PC density in the autism 
cases argues against a lifelong progressive loss of PCs in this disorder.  The initial 
neuropathological studies from members of our group predicted that the 
decreased density of PCs observed in the cerebella of autistic individuals may be 
due to the loss of these neurons during the late prenatal period (Kemper and 
Bauman 1993).  This prediction was based on the observation that the inferior 
olivary neurons in the brain stem of individuals with autism are preserved 
despite reduced PC densities.  The intimate relationship between inferior olivary 
neurons and PCs is established in late gestation, and the loss of PCs in term and 
older aged infants is typically associated with inferior olivary degeneration.  In a 
follow-up investigation, Whitney et al. noted in the autistic brain that there was a 
preservation of basket and stellate cells in areas with decreased PCs, which 
indicates that the PCs in these regions established their usual relationship with 
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these interneurons in late gestation and were subsequently lost (Whitney et al. 
2009).  
 
Comments, Limitations, and Future Directions 
Neuronal density can be affected by both changes in tissue volume as well 
as neuronal number.  Therefore, we have demonstrated that the contribution of 
tissue volume to a subset of our findings is indeed significant.   
Our study was limited by a small sample size, but each case was 
systematically analyzed using precise methods that allowed for the identification 
of consistent and potentially behaviorally relevant alterations in regional PC 
density in autism.  Fewer female cases than would be ideal in making gender 
comparisons were available and thus these comparisons should be viewed as 
strictly preliminary.  Additionally, the age range of the study was not as wide as 
in prior studies that identified an age-related decline in PC density. Therefore, 
future analyses in older patients may demonstrate a different trajectory of age-
related PC decline in the autism population.  Furthermore, due to the age range 
of our study, it was not possible to assess the early developmental processes that 
are believed to be crucial in understanding autism development but that occur 
prior to the age at which autism can be diagnosed.  For a better understanding of 
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early development, we may need to rely on animal models, as well as further 
advancements in in utero longitudinal bioimaging techniques and efforts to 
identify clinically relevant prenatal biomarkers (Saksena et al. 2008, Van Kooij et 
al. 2012).  To better understand the relationship between neuropathology and 
behavioral symptomatology in autism, it will be necessary to obtain more 
detailed qualitative as well as quantitative behavioral measures from tissue 
donors.   
Current investigations are underway to determine biochemical differences 
in crus I and II that distinguish these regions from other cerebellar regions in an 
attempt to better characterize the pathophysiology of autism. 
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Figure 2. Cerebellar Regions Investigated 
  This flatmap diagram displays the four cerebellar regions of interest for 
our stereological assay. Hemispheric lobules IV-VI (in yellow) are bordered by 
the preculminate and superior posterior fissures, lateral to the fourth ventricle. 
Crus I (in blue) is the region bordered by the superior posterior and horizontal 
fissures.  Crus II (in green) is bordered by the horizontal and ansoparamedian 
fissures.  Lobule X, the flocculonodular lobe (in orange), is bordered by the 
posterolateral fissure.  This image is an adaptation of the diagram by Larsell, 
1958. 
 
 
 
Preculminate fissure 
Superior posterior fissure 
Horizontal fissure 
Ansoparamedian fissure 
Posterolateral fissure 
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Figure 3. Stereological Assessment of PC Density 
This figure depicts our stereological approach for quantifying PC density 
in each region of the cerebellum.  3a displays a full sagittal section of the human 
brain.  3b represents the positioning of contour lines used to select the 
boundaries around each region of interest, within which sampling occurs.  
Lobules IV-VI are highlighted in green, crus I is highlighted in pink, crus II is 
highlighted in blue, and the flocculus of lobule X is highlighted in orange at the 
bottom of the section.  3c displays a hypothetical placement of counting frames 
(optical disector probes) within lobules IV-VI.  The counting frame size has been 
increased to aid in visualization for this example.  The white dotted line displays 
the randomly imposed grid over the contour, which regulates the distance 
between counting frames along the X-Y plane of the section.  A counting frame is 
placed in the top-left of each grid cell if it will include a portion of the region of 
interest as designated by the contour line.  Finally, 3d displays a histological 
section with an imposed counting frame that includes two PCs to be counted.  
The use of the optical disector probe dictates that PCs are counted when within 
the counting frame or at all touching the green line, but never when cells 
intersect with the red line. 
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Figure 3a 
 
Figure 3b 
 
 
Preculminate fissure 
Superior posterior fissure Horizontal fissure 
Ansoparamedian fissure 
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Figure 3c 
 
Figure 3d 
63 
Figure 4. Regional PC Density 
This graph demonstrates the findings from our linear mixed models 
(Table 2).  Mean PC density was lower in the autism group in each region 
assayed, but this finding was most prominent in crus I and II (marked with *), 
where there was 19.8±9% and 21.7±9% lower PC densities, respectively (p = 0.039 
and p = 0.032, t-test).  (See the results of this test in Table 3).  Lobule X PC density 
was lower in the males with autism (marked with ‡) than in control males (p = 
0.05), and lower than female cases in the autism group (p = 0.022).  Bars represent 
mean ± standard deviation.  The number of subjects for each test from each 
diagnostic group and their gender are represented in the results tables (Tables 2 
and 3). 
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Figure 5. Overall PC Density Decreases with Age 
Overall PC density obtained from the anterior, posterior, and 
flocculonodular lobes negatively correlates with age (R2 = -0.39 ±0.14, p = 0.030).  
Some cases were missing data from an individual region (as described in 
Methods) and were not included: one female and one male case from the autism 
and control groups were not included. 
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Figure 6. Lobule X PC Density is Associated with Direct Gaze  
Lobule X PC density in the autism group negatively correlated with ADI-
R question 50, which assessed the social and communicative use of eye contact 
(R2 = -0.75 ±0.04, p = 0.012).  One case from the autism group was lacking 
sufficient ADI-R data to be included in this analysis. 
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Figure 7. Models of PC Arrangement 
These figures represent the importance of estimating PC density in 3-
dimensional space rather than along a 1-dimensional line (PC/mm3 rather than 
PC/mm).  7a and 7b display two views of a 3-D model of a cerebellar folium, in 
which PCs (black) are arranged in a monolayer apposed to the granule cell layer 
(blue) that surrounds a central white matter tract (white).  7b displays two slices, 
one perfectly parallel to a plane of PCs, and the other, more realistically, 
transverse to this plane. 7c and 7d are cartoons demonstrating the PC 
arrangement within the parallel and transverse slice, respectively. Notice in 7d 
the PC layer is thicker, the degree to which depends on the slice position.  Also 
notice that the selection of which PCs lie perfectly along a line is ambiguous (a 
few examples have been circled in red).  This ambiguity introduces human error 
when performing an estimate of PC/mm that is eliminated in 3-dimensional 
estimates of PC/mm3 as are utilized in this study. 
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Figure 7a 
 
 
 
Figure 7b 
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Figure 7c 
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Figure 7d 
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Figure 8. Photomicrograph of Transverse Section 
This photomicrograph is an illustrative example of the arrangement of 
PCs on a transverse section.  The PCs (purple) go out of focus to the left as the PC 
layer curves through the depth of the tissue section.  The granule cell layer (blue) 
is visible below the PC layer, the molecular layer surrounds the PC layer (seen 
here as sparsely stained space), and the white matter tract is out of view to the 
right.  Nissl-stained section from the celloidin collection used in this study, 
reference bar = 100µm.  
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 Table 1. Clinical Characteristics 
  Clinically relevant features of each postmortem case investigated are 
presented in Table 1.  Case numbers were maintained from the ATP records. 
a Fresh brain weight (in grams) was measured prior to tissue processing 
b Postmortem interval 
c Mental Retardation 
d Left brain hemisphere was investigated.  (All other cases were investigated 
from the right brain hemisphere). 
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Table 1. Clinical Characteristics 
Case Sex Age 
Brain 
Weighta 
PMIb MRc Epilepsy Regression Cause of Death 
AUTISM CASES 
B-
6115d 
F 17 1158 25 no no no 
Dilated 
cardiomyopathy 
B-
6403 
M 7 1610 25 no yes yes Drowning 
UMB-
1627 
F 5 1390 13.3 no no no Auto trauma 
IBR-
93-01 
M 23 1610 14 no yes no Drowning 
B-
6276 
M 56 1570 3.4 
moderate 
MR 
no no 
Arteriosclerotic 
heart disease 
B-
6212 
M 36 1480 24 
severe 
MR 
no yes 
Circulatory 
failure, renal 
failure 
UMB-
1638 
F 21 1108 50 mild MR yes yes 
Obstructive 
pulmonary 
disease 
B-
5666 
M 8 1570 22.2 no no no Sarcoma 
CONTROL CASES 
UMB-
1843 
F 15 1250 9 no no N/A 
Multiple 
Injuries 
UMB-
1846 
F 20 1340 9 no no N/A 
Multiple 
Injuries 
UMB-
4898 
M 7 1240 12 no no N/A Drowning 
B-
6736 
F 4 1530 17 no no N/A 
Acute broncho-
pneumonia 
UMB-
1646 
M 23 1520 6 no no N/A 
Ruptured 
spleen 
BTB-
3983 
M 52 1430 12.5 no no N/A 
Atherosclerotic 
cardiovascular 
disease 
UMB-
1576 
M 32 - 24 no no N/A 
Compressional 
asphyxia 
IBR-
252-
02d 
M 51 1450 18 no no N/A 
Myocardial 
infarct 
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Table 2. Linear Mixed Models a 
 
a Outlined yellow cells in the upper table of test results designate the target 
results for each variable and interaction:  Test 1 was designed to investigate the 
overall effect of gender and autism diagnosis on PC density. It incorporated 
cerebellar regional volume as a WLS weight to adjust the test’s significance 
relative to the regional volume for each PC density measurement. Test 3 was 
designed to test the regional differences in PC density as an effect of gender and 
diagnosis. Tests 2 and 4 are designed to investigate the contribution of fresh 
brain weight (grams), as a correlate of tissue volume (Witelson et al. 2006), to 
Tests 1 and 3, respectively.   
The bottom table lists supportive information about each test.  
 
b One control male case was missing brain weight information. 
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Table 2. 
  
 
1 (2) 3 (4) 
  
F p-value F p-value F p-value F p-value 
Variables diagnosis 6.050 0.020 7.515 0.010 7.407 0.015 9.583 0.007 
 
gender 4.802 0.036 3.697 0.068 6.373 0.022 4.423 0.054 
 
region 7.159 0.001 6.652 0.001 33.783 0.000 36.031 0.000 
Interactions diagnosis * gender 0.014 0.905 0.214 0.648 0.000 1.000 0.340 0.568 
 
diagnosis * region 0.965 0.418 1.414 0.253 0.380 0.768 0.401 0.753 
 
gender * region 2.281 0.093 3.171 0.035 2.093 0.115 2.291 0.093 
 
gender * diagnosis * region 1.615 0.200 2.013 0.128 3.946 0.014 5.078 0.005 
Covariables brain weighta     0.372 0.551     0.311 0.585 
 
 
Statistical Test Covariate Residual Weight Number of Cases Autism (M/F) Control (M/F) 
1 
 
Regional volume 16 8 (5/3) 8 (5/3) 
(2) Brain weight (g) Regional volume 15 8 (5/3) 7 (4/3)b 
3 
  
16 8 (5/3) 8 (5/3) 
(4) Brain weight (g) 
 
15 8 (5/3) 7 (4/3)b 
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Table 3. Regional Differences in Purkinje Cell Density  
 
Region t df p-value Austism (M/F) Control (M/F) 
Lobules IV-VI 0.677 11 0.512 6 (4/2) 7 (4/3) 
Crus I 2.293 13 0.039a 8 (5/3) 7 (5/2) 
Crus II 2.407 13 0.032a 8 (5/3) 7 (5/2) 
Lobule X 1.44 13 0.173 8 (5/3) 7 (5/2) 
 
a Met the cutoff for false discovery rate. 
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CHAPTER 2 
The following manuscript was prepared to be submitted for publication in 
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HISTAMINERGIC H1 AND Α7 CHOLINERGIC COMPONENTS OF 
NEURAL SYSTEMS MODULATING PRE-PULSE INHIBITION 
Authors: J. Skefos1, M.S. Ghulam1, A. Mahendra1, G. Patel1, J. Larrauri2, E. 
Kholdebarin2, E.D. Levin2, and M.L. Bauman1 
1 Boston University School of Medicine, Boston, MA 
2 Duke University Medical Center, Durham, NC 
 
Abstract 
Sensory gating is a way by which the brain manages sensory information 
flow. For optimal allocation of neural resources, it is important to be able to 
screen out irrelevant sensory information. Impaired sensory gating is seen in a 
variety of neurobehavioral disorders including schizophrenia, autism and 
sensory processing disorder. The degree of sensory gating can be studied 
behaviorally by indexing pre-pulse inhibition (PPI). PPI reflects the degree of 
suppression of a startle response to an intense sensory stimulus when it is 
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preceded by a more modest sensory stimulus. The neural circuitry underlying 
PPI has been shown to include dopaminergic and cholinergic systems. We found 
that histaminergic H1 receptors play important roles in sensory gating. The 
histamine H1 antagonist, pyrilamine, significantly reverses the PPI impairment 
caused by the NMDA glutamate antagonist, dizocilpine (MK-801). The current 
study was conducted to determine the anatomic bases for histaminergic and 
cholinergic regulation of the effect of NMDA antagonism on PPI.  We found that 
pyrilamine treatment decreased H1 receptor binding in the anterior cingulate, 
which correlated with PPI improvement.  Further, we found that pyrilamine 
treatment resulted in increased α7-nicotinic acetylcoline receptor binding in the 
insular cortex, which also correlated with PPI improvement.  These findings shed 
light on the interaction between histamine and acetylcholine signaling in a 
distributed network of PPI modulation. 
 
Introduction 
Sudden intense sensory stimuli can evoke a rapid muscular reaction, a 
reaction termed the startle response. The startle response can be inhibited by a 
shortly preceding milder sensory stimulus (prepulse) in a phenomenon termed 
prepulse inhibition (PPI). PPI can involve any combination of visual, tactile, or 
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auditory stimuli.  PPI is believed to entail sensory gating mechanisms as well as 
direct motor reflex inhibition. An expansive network of brain regions underlies 
startle, PPI and modulation of PPI. This includes nuclei within the pontine 
reticular system, the superior and inferior colliculi, substantia nigra, basolateral 
amygdala, hippocampus, thalamus, prefrontal cortex, ventral pallidum, striatum, 
and ventral tegmental area (Swerdlow et al. 2001).  In humans, the PPI measure 
is believed to relate to an individual’s ability to filter incoming sensory 
information as well as inhibit resultant behavior (Braff et al. 2001, Rabin et al. 
2009), and has been shown to be impaired in a number of neuropsychological 
disorders including schizophrenia and autism (Braff et al. 2001). PPI is a useful 
experimental technique used to investigate sensory gating mechanisms and test 
therapeutic treatments in animal models of neurologic disease as well as clinical 
populations (Swerdlow et al. 2008).   
The aim of this study was to investigate an established rat model of 
decreased PPI induced by chronic administration of the NMDA antagonist, 
dizocilpine (Mansbach and Geyer 1989), and the reversal of this PPI impairment 
by the histaminergic H1-antagonist, pyrilamine.  H1-antagonism is a potential 
mechanism of the therapeutic effects of the atypical antipsychotic, clozapine, 
which improves PPI following dizocilpine administration in rats as well as in 
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patients with schizophrenia (Kumari and Sharma 2002, Levin et al. 2007, Roegge 
et al. 2007).  Here we show that chronic pyrilamine administration prevents the 
PPI impairment induced by chronic dizocilpine administration, an effect that is 
correlated with a reduction in ligand-binding potential of H1 receptors in the 
anterior cingulate and an increase in nicotinic receptor α7 subunit binding in the 
insular cortex.  In light of the functional anatomical connectivity of the anterior 
cingulate and insular cortex, both of which interact extensively with the core PPI 
network, our findings support the inclusion of both cortical areas in an expanded 
network capable of regulating sensorimotor gating. 
 
Methods 
Animals  
Thirty six adult female Sprague-Dawley rats (9 per treatment condition) 
were used for the studies. The rats were housed in groups of three in a 
temperature-controlled vivarium on a 12:12 reverse light dark cycle with ad lib 
access to food and water. They were tested during the dark phase.  
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Equipment  
Acoustic startle reflex amplitude was measured and prepulse inhibition 
calculated with the Med Associates Startle Reflex System (St. Albans, VT, USA). 
The equipment included response platforms that were placed in sound 
attenuating chambers.  Each platform was calibrated with a spinner type 
calibrator (Med Associates Startle Calibrator).  A speaker was placed within the 
chamber midway along the long axis of the platform. The sound intensity of the 
speaker in each chamber was calibrated (Digital Sound Level Meter, Extech 
Instruments).  Plexiglas cylinders large enough to allow animals to turn around 
(7.5 cm diameter), were mounted on the platforms.  The white noise background 
noise was a constant 65 dB.  
 
Behavioral Procedure   
The test session was conducted in 3 blocks.  After the animals were placed 
in the chambers, there was a 5 min acclimation period before testing began.  
Block 1 consisted of 6 startle only trials 110 dB white noise stimulus.  Block 2 had 
a total of 48 trials: 12 startle only trials and 36 prepulse plus startle trials.  Within 
the prepulse trials there were 3 prepulse levels:  68, 71, and 77 dB pure tone.   The 
trials were presented in random order with the inter-trial duration ranging from 
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10-20 seconds.  Block 3 had an additional 5 trials of startle only.  Each stimulus 
had a 2 msec rise/fall time.  The null period was 100 msec and the prepulse-to-
startle delay was 100 msec onset to onset.  The entire test period lasted 
approximately 34 mins.  
 
Drug treatment 
Dizocilpine (MK-801) (0.15 mg/kg/day) was administered via 
subcutaneously implanted 2ML4 osmotic minipumps for 4 weeks.  Control 
animals were administered vehicle during this period, and pyrilamine (50 
mg/kg/day) was similarly administered with (n = 9) or without (n = 9) 
dizocilpine.  Each week, the rats were tested for PPI, and before the final testing 
session on week 4, pharmacological treatments were withdrawn for one day. 
 
Quantitative Receptor Autoradiography  
Following behavioral analyses, animals were anesthetized with Euthasol 
(100 mg/kg, Virbac, Inc., Fort Worth, TX, USA) and then sacrificed by 
exsanguination. Brains were immediately removed and stored at -80°C.  To 
prepare histological sections, each brain was sliced coronally at 20µm thickness 
using a cryostat (Bright Instruments, Cambridgeshire, UK) and sections were 
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mounted on gelatin-subbed slides.  All radioligands were purchased from 
American Radiolabeled Chemicals (Saint Louis, MO).  Specific binding of the α7 
subunit of the acetylcholine receptor was determined using [125I]α-bungarotoxin 
(5nM, 147Ci/mmol), and specific binding of the histamine H1 receptor was 
determined using [3H]pyrilamine (5nM, 20Ci/mmol).  Radioligands were diluted 
in a chilled buffer containing 50nM Tris-HCl and 1mg/ml BSA, pH 7.4 and the 
entire radioligand binding protocol was performed on ice to limit nonspecific 
binding.  Slides were first pre-incubated in buffer for 1 hr, after which they were 
incubated with the appropriate radioligand solution for 1 hr.  Non-specific 
binding was assessed by co-incubation with L-nicotine (4µM) or nonradioactive 
pyrilamine (2 µM) for the α7 subunit and H1-receptor, respectively.  Following 
incubation in radioligand solution, the slides were washed for 15 min in three 
changes of chilled buffer, then subsequently dried with blown air at room 
temperature.  Sections were then exposed to film (Kodak, Hyperfilm) for 22 days 
to visualize α7 subunit labeling and approximately 6 weeks to visualize 
pyrilamine labeling.  Films were scanned (Epson, Perfection V750 Pro) and 
analyzed densitometrically using Image-J (Schneider et al. 2010).  Each film was 
exposed to the appropriate set of radioactive standards, and densitometric data 
was converted to fmol/mg tissue equivalent (TE). 
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Radioligand binding was quantified within a distributed network of brain 
regions (Fig. 9) previously implicated in regulating PPI of startle (Swerdlow et al. 
2001).  The regions we investigated within this network included the inferior 
colliculus, amygdala, and hippocampus.  Within the amygdaloid complex, we 
sampled within specific groups of nuclei: the basolateral group, the cortical 
group, and the centromedial group (Sah et al. 2003), and within the hippocampal 
complex, we sampled CA1-3 of the hippocampus proper, as well as the dentate 
gyrus.  Additionally, we qualified radioligand binding in the anterior cingulate 
and insular cortex, both of which are known to interact with the PPI network and 
have been preliminarily implicated in fMRI investigations of PPI in humans 
(Campbell et al. 2007, Kumari et al. 2007).  A stereotaxic atlas (Paxinos et al. 2005) 
was used to confirm that each brain region was sampled consistently, and data 
from each brain hemisphere were averaged prior to statistical analysis. 
 
Statistical Analysis 
To assess differences between group means on the basis of pharmacologic 
treatment, we utilized ANOVA.  Post-hoc comparisons were performed using 
Tukey’s HSD.  Furthermore, to assess the overall effects of pyrilamine treatment, 
rat data was clustered into two groups (with and without pyrilamine treatment) 
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and independent samples t-tests were performed.  The appropriate t-test was 
chosen based on the results of Levene’s test of equality of variances between each 
group.  For brain regions that demonstrated significant differences in radioligand 
binding between groups, Pearson correlations were performed to test the 
association between radioligand binding and PPI.  All statistical tests were two-
sided, with an alpha level of 0.05.  Confidence intervals were set at 95% for all 
comparisons, and for correlations, these intervals were determined using 
bootstrapping with 1,000 replications.  Statistical computations were performed 
with SPSS Version 19 (IBM, Armonk, NY, USA). 
 
Results 
1. Pyrilamine treatment reverses PPI impairment in dizocilpine-treated rats. 
 Although prepulse intensity did not significantly affect inhibition of the 
baseline startle response, we did observe a trend of increased PPI with increased 
prepulse intensity (Fig. 10).  For trials using the 77 dB prepulse, ANOVA 
demonstrated a significant effect of pharmacologic treatment (p = 0.026), with 
pyrilamine administration significantly recovering the PPI that was consistently 
low in rats treated with dizocilpine (p = 0.021).   
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2. Pyrilamine treatment decreases H1-receptor binding in the Anterior Cingulate, an 
effect correlated with PPI improvement. 
Within the anterior cingulate, pyrilamine treatment induced a 37 ± 19% 
decrease in H1-receptor binding that was nearly significant (p = 0.058) (Fig. 11).  
This change correlated with PPI such that decreased H1-receptor binding was 
associated with increased mean PPI of all three prepulse intensities (Fig. 12, R2 = -
0.15,  p = 0.05).   
 
3. Acetylcholine receptors in the Insular Cortex are likely involved in pyrilamine-induced 
PPI improvement. 
 Within the insular cortex, pyrilamine treatment induced a 9 ± 3% increase 
in α7 ACh-receptor binding (p = 0.002) (Fig. 13).   Increased α7 ACh-receptor 
binding was correlated with increased mean PPI of all three prepulse intensities 
(Fig. 14, R2 = 0.24, p = 0.004). 
 
4. Alternative mechanisms of pyrilamine-induced PPI improvement. 
The data from this study imply that pyrilamine modulates PPI of startle 
through diverse mechanisms that are regionally discrete.   In the anterior 
cingulate, α7 ACh-receptor binding was positively correlated with mean PPI 
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(Fig. 15, R2 = 0.14, p = 0.027); however, α7 ACh-receptor binding in this region 
was not significantly affected by pyrilamine treatment (p = 0.507).   Likewise, 
pyrilamine treatment did not affect H1-receptor binding in the insular cortex (p = 
0.237), and H1-receptor binding in the insula was not associated with mean PPI 
(p = 0.702).  In the other brain regions investigated (inferior colliculus, amygdala, 
and dorsal hippocampus), neither H1-receptor binding nor α7 ACh-receptor 
binding was associated with PPI.    
 
Discussion 
Sensorimotor gating impairments have been observed in patients with 
sensory processing disorder (Davies et al. 2009), Parkinson’s disease (Nakashima 
et al. 1993), schizophrenia (Braff et al. 2001), non-epileptic seizures (Pouretemad 
et al. 1998), Tourette’s syndrome and ADHD (Castellanos et al. 1996), nocturnal 
enuresis (Ornitz et al. 1992), blepharospasm (Gómez-Wong et al. 1998), 
obsessive-compulsive disorder (Swerdlow et al. 1993, Hoenig et al. 2005), panic 
disorder (Ludewig et al. 2002), bipolar disorder (Perry et al. 2001, Rich et al. 
2005), Huntington’s disease (Swerdlow et al. 1995), Fragile X syndrome (Hessl et 
al. 2009), and autism (Perry et al. 2007).  In humans, sensory gating measures 
such as PPI have been found to correlate with a growing list of behavioral 
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symptoms, including neuroticism, disinhibition on the go/no-go task, 
premonitory urges in Tourette’s syndrome, high trait anxiety in panic disorder, 
restricted/repetitive behavior in autism, and in schizophrenia: positive and 
negative symptoms, semantic priming abnormalities, perseveration, information-
processing deficits and thought disorder, distractibility, and violent behavior  
(Perry and Braff 1994, Karper et al. 1996, Vinogradov et al. 1996, Braff et al. 1999, 
Corr et al. 2002, Ludewig et al. 2002, Perry et al. 2007, Rabin et al. 2009, Yadon et 
al. 2009). 
The present study employed a bimodal PPI paradigm, in which a tactile 
startle stimulus was immediately preceded by an auditory prepulse expected to 
induce significant gating of the startle response.  Chronic administration of the 
NMDA antagonist, dizocilpine, caused a considerable deficit in sensorimotor 
gating, demonstrated by a consistently low PPI of the startle response in 
dizocilpine-treated rats (mean PPI of 5.6%).  This deficit was entirely reversed by 
co-administration of the selective histaminergic H1-receptor antagonist, 
pyrilamine (Fig. 11).   
Dizocilpine disruption of PPI has been previously used to model 
sensorimotor gating impairments (Mansbach and Geyer 1989, Geyer et al. 2001).  
The predictive validity of this model is supported by the fact that the atypical 
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antipsychotic, clozapine, reverses PPI impairment in this model (Levin et al. 
2007, Lim et al. 2012) as it does similarly in humans (Nagamoto et al. 1996, Adler 
et al. 1998). Here we show that pyrilamine treatment mimics the effect of 
clozapine, reversing PPI impairment in the dizocilpine-treated rat.  As clozapine 
has been shown to saturate the brain’s H1-receptors at therapeutic concentrations 
(Humbert-Claude et al. 2012), this may provide an important mechanism of 
clozapine’s therapeutic action.   
In the mammalian brain, histaminergic fibers originating in the 
tuberomammilary nucleus of the posterior hypothalamus regulate the response 
to noxious stimuli (Itoh et al. 1989) and infection (Saper et al. 2012), and also 
regulate the excitability of arousal circuits (Tasaka et al. 1989). One mechanism of 
histamine’s effects on arousal is through regulation of cholinergic transmission in 
the nucleus basalis of Myenert in the basal forebrain (Bacciottini et al. 2001, 
Dringenberg et al. 2003).  Histamine’s cholinergic effects have been shown to 
differ regionally in the brain: in the frontopariental cortex, local histamine 
administration inhibited acetylcholine release by 50% (Blandina et al. 1996), 
whereas histamine application to the nucleus basalis has been shown to double 
cholinergic output to the cortex in rats (Cecchi et al. 1998).  The complicated 
interactions between histaminergic signaling and cholinergic tone throughout 
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the brain awaits further elucidation; however, it has been shown that 
tuberomammilary lesions or systemic administration of the H1 antagonists, 
chlorpheniramine and pyrilamine, are similarly capable of significantly 
increasing cortical acetylcholine dose-dependently (Dringenberg et al. 1998).  
Further, members of our group have recently shown that pyrilamine treatment 
reduces nicotine self-administration in rats (Levin et al. 2011).  So it is believed 
that systemic H1 antagonists modify behavior in part by increasing cortical 
cholinergic transmission.  
The role of histaminergic signaling in PPI has not been extensively 
studied, but of the disorders investigated to date that are associated with 
sensorimotor gating abnormalities, all have displayed increased histaminergic 
neurotransmission.  These include: Parkinson’s disease (Rinne et al. 2002), 
Tourette’s syndrome (Fernandez et al. 2012), bipolar disorder (Jin et al. 2009), 
Huntington’s disease (van Wamelen et al. 2011), and schizophrenia (Ito 2004, 
Arrang 2007).  In Alzheimer’s dementia, interestingly, researchers found 
significantly decreased histamine levels in the frontal and temporal cortices 
(Mazurkiewicz-Kwilecki and Nsonwah 1989), and normal PPI (Hejl et al. 2004). 
Prior work by members of our group demonstrated the ability of a single 
dose of pyrilamine to attenuate PPI impairment in rats acutely administered 
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dizocilpine or amphetamine (Roegge et al. 2007, Larrauri 2010).  The current 
study was designed to further explore this phenomenon pharmacologically in 
rats chronically administered dizocilpine and/or pyrilamine, a scenario more 
analogous to long-term therapeutic enhancement of sensorimotor gating in 
humans.  Our aim was to determine which components of the distributed PPI 
network were impacted by pyrilamine treatment to improve PPI.   
Pyrilamine treatment resulted in decreased H1-receptor binding in the 
anterior cingulate, which was correlated with PPI improvement (Fig. 11 & 12). 
Functional involvement of the anterior cingulate in PPI has been previously 
demonstrated through lesion as well as fMRI and PET studies (Hazlett et al. 
1998, Yee 2000, Goldman et al. 2006, Campbell et al. 2007, Neuner et al. 2010), 
and this region is known to express a high concentration of H1-receptors 
(Tagawa et al. 2001).  As a site of limbic and cortical integration, the anterior 
cingulate modulates conditioned fear responses and arousal (Hamner et al. 1999).  
The anterior cingulate has been shown to send efferent projections to the 
amygdala (Wang et al. 2009), a wide distribution of thalamic nuclei (Fujii et al. 
1983), substantia nigra (Beckstead 1979), nucleus accumbens (Sesack et al. 1989), 
globus pallidus (Beckstead 1979), and superior colliculus (Sesack et al. 1989), all 
regions implicated in regulating PPI of the startle response (Yamada et al. 1998, 
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Fendt and Yeomans 2001, Hazlett et al. 2001, Takahashi et al. 2007, Forcelli et al. 
2012).  Efferents of the anterior cingulate have even been traced to the giant 
neurons of the caudal pontine reticular nucleus, which display prepulse-
inhibited membrane potential and are believed to be an integral component of 
the acoustic startle response (Sesack et al. 1989, Lingenhöhl and Friauf 1994).  
Similarly, anterior cingulate efferents were traced to the adjacent 
pedunculopontine tegmental nucleus (Sesack et al. 1989), which is an established 
component of the core brainstem PPI circuitry that directly modulates the 
pontine reticular giant neurons through cholinergic innervation (Fendt and 
Yeomans 2001).  We have shown that α7 ACh-receptor binding in the anterior 
cingulate is positively correlated with PPI (Fig. 15), so it is possible that 
cholinergic signaling in this region plays a role in PPI.  Indeed, nicotine has been 
shown to increase activity in the anterior cingulate while improving PPI (Postma 
et al. 2006).  However, we found no effect of pyrilamine on the α7 ACh-receptor 
binding in the anterior cingulate, implicating an alternate mechanism of 
pyrilamine enhancement of PPI in this brain region. 
Contrary to the anterior cingulate, the insular cortex displayed a 
significant increase in α7 ACh-receptor binding in pyrilamine-treated rats that 
was positively correlated with PPI (Fig. 13 & 14). However, there was no change 
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in H1-receptor binding in the insula of rats that were pyrilamine-treated.  
Because H1 antagonists have been shown to be ineffective in regulating insular 
cortical excitability when directly applied to this region (Takei et al. 2012), 
pyrilamine treatment may modulate insular acetylcholine signaling indirectly. 
The insular cortex contains a high concentration of nicotinic receptors, and has 
shown increased activation following nicotine administration in patients with 
schizophrenia whose PPI was improved by nicotine (Postma et al. 2006).  
Agonism of α7 ACh-receptors has been demonstrated to improve sensory gating 
in patients with schizophrenia (Martin and Freedman 2007), and has proven 
beneficial in animal models of not only gating impairments (Cilia et al. 2005, 
Hajós et al. 2005, Thomsen et al. 2009) but also positive and negative symptoms 
of schizophrenia (Hauser et al. 2009).  Therefore, it is likely that pyrilamine-
induced increases in insular α7 ACh-receptor expression contribute to the 
observed improvement in PPI. 
Due to its anatomic connections, the insular cortex is believed to integrate 
the processing of autonomic responses with that of ongoing behavioral plans and 
emotional states (Allen et al. 1991).  The insula is anatomically poised to 
influence top-down processing of sensorimotor gating, with both direct as well 
as indirect connections to the pontine reticular startle circuit. The insula send 
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largely reciprocal projections to the amygdala and mediodorsal nucleus of the 
thalamus (Shi and Cassell 1998), substantia nigra, raphe nucleus, ventral 
pallidum, and ventral striatum (Reep and Winans 1982), all of which have been 
associated with regulation of PPI (Young et al. 1995, Fendt and Yeomans 2001, 
Adams et al. 2008, Baldan et al. 2011, Forcelli et al. 2012).  The insula have 
furthermore been shown to be involved in distinguishing successive stimuli 
presented with a short interstimulus time interval as is required to elicit PPI 
(Kosillo and Smith 2010).   
Although the anterior cingulate and insular cortex have been shown to be 
highly interconnected functionally (Di Martino et al. 2009, Medford and 
Critchley 2010, Cauda et al. 2011), there was no correlation between the changes 
we report in pyrilamine binding in the anterior cingulate and α-bungarotoxin 
binding in the insular cortex.  The anterior cingulate and insular cortex both send 
projections to regions that are known to directly modulate the startle response 
through interaction with the pontine reticular nuclei responsible for this reflex.  It 
is therefore possible that pyrilamine treatment modified the activity of the 
anterior cingulate and insular cortex independently to improve PPI, although 
further research is necessary to understand the interaction between anterior 
cingulate and insular cortical networks in modulating startle inhibition.  This 
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study demonstrates the wide distribution of networks capable of influencing PPI 
of startle, supporting the importance of the PPI measure as a tool to analyze 
interactions between multiple hierarchies of neuronal processing in disparate 
brain regions, particularly in pathological states.  It will be important to further 
investigate effects of pharmacological treatments on PPI in humans as well as 
animal models of disease to elucidate the neuronal machinery underlying 
sensory filtering and behavioral inhibition.  The involvement of H1 receptors in 
PPI has not only been demonstrated in pharmacologically induced PPI 
disruption models, but also in models of developmental disturbance that show 
PPI impairment.  In a mouse model of isolation rearing, pyrilamine treatment or 
H1 receptor knockout were capable of preventing PPI impairment (Dai et al. 
2005) similarly to clozapine (Möller et al. 2011).  Along these lines, further 
research into the histaminergic regulation of PPI is warranted, as H1-antagonists 
have demonstrated a low incidence of side effects in clinical trials (Pearlman et 
al. 1997, Lankford et al. 2012). A recent initial clinical study has shown that the 
antihistamine meclizine significantly improves PPI in people who have less than 
typical PPI and exaggerated startle response (Rosenthal and Levin 2013). 
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Figure 9: Diagram of brain regions investigated. 
Each of the regions investigated with autoradiography are shown in light 
grey and are labeled.  The colored highlighted portions of each region 
demonstrate the precise location within which our autoradiographic analyses 
were performed.  This figure was generated from a 3-D stereotaxic rat brain atlas 
software (Brain Navigator release 2.0, 2009).  
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Figure 10. Pyrilamine treatment recovers dizocilpine-induced reduction in PPI. 
  At each prepulse decibel (dB) level employed, the general pattern of 
pharmacologic manipulation of PPI was maintained.  However, in agreement 
with the prior reports, increased prepulse intensity was associated with stronger 
prepulse inhibition.  Error bars represent standard error of the mean. 
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Figure 11. Pyrilamine treatment results in decreased H1 receptor binding in the 
anterior cingulate. 
An overall effect of pyrilamine treatment was a reduction in H1-receptor 
binding in the anterior cingulate (AC).  This was a near significant trend that will 
require further investigation to confirm (p = 0.058). 
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Figure 12. H1 receptor binding in the anterior cingulate correlated with PPI. 
We observed a negative correlation between H1 receptor binding in the 
anterior cingulate (AC) and PPI, such that lower H1 binding in the AC was 
associated with higher PPI.  Data are displayed for the 77 dB prepulse trials for 
which PPI was greatest.  Notice that some rats (irrespective of pharmacologic 
treatment) did not demonstrate the PPI phenomenon: this is a common 
occurrence in PPI studies and reflects inter-individual differences. 
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Figure 13. Pyrilamine treatment results in increased α7-nicotinic receptor 
binding in the insula. 
An overall effect of pyrilamine treatment was an increase in α7-nicotinic 
receptor binding in the insular cortex. 
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Figure 14. α7 receptor binding in the insular cortex correlated with PPI. 
We observed a positive correlation between α7-nicotinic receptor binding 
in the insular cortex and PPI, such that greater α7 binding in the insula was 
associated with higher PPI.  Data are displayed for the 77 dB prepulse trials for 
which PPI was greatest.  Notice that some rats (irrespective of pharmacologic 
treatment) did not demonstrate the PPI phenomenon: this is a common 
occurrence in PPI studies and reflects inter-individual differences. 
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Figure 15. α7 receptor binding in the anterior cingulate correlated with PPI. 
Although pyrilamine treatment did not affect α7 receptor binding in the 
anterior cingulate (AC), we did observe a positive correlation between α7 
receptor binding in this region and PPI.  This indicates that α7 receptors in the 
AC may contribute to PPI independently of H1 receptor-mediated signaling.  
Notice that some rats (irrespective of pharmacologic treatment) did not 
demonstrate the PPI phenomenon: this is a common occurrence in PPI studies 
and reflects inter-individual differences. 
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CHAPTER 3 
 
INVESTIGATION OF SEX HORMONE EXPRESSION CHANGES  
AND NEUROIMMUNE DYSREGULATION WITHIN CEREBELLAR 
LOBULE VII IN AUTISM 
Jerry Skefos, Katelyn Enzer, Ian Traniello, Heather Baldwin, Margaret Bauman 
Abstract 
Recent reports have implicated neuroimmune dysregulation in a subset of 
individuals with autism highlighting a possibly important role of the immune 
system in this disorder.  Additionally, researchers have postulated that aberrant 
neuroendocrine sex-hormone production and signaling may impact on the 4:1 
male-to-female ratio of autism’s prevalence.   For these studies we used lobule 
VII of the cerebellum, a region implicated in a number of neuropathology 
investigations of autism.  Within this region, we employed western blots to 
quantify a set of proteins related to the neuroimmune and neuroendocrine 
systems and determined correlations between these protein concentrations  and 
behavioral symptom severity.  Our findings did not provide evidence of 
dysregulation of these proteins in autism.  The limitations of our methodology 
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are discussed, as well as comparisons to other studies and suggestions for future 
investigations. 
 
Introduction 
The increasing prevalence of autism spectrum disorders is difficult to 
explain since so little is known about the core neurobiological features that 
underlie the behavioral manifestations of these disorders (Hertz-Picciotto 2009, 
Lord and Bishop 2009, Fombonne 2009, Palmen et al. 2004). Classically, 
neuroanatomic abnormalities have been noted throughout the limbic system, 
frontal lobes, and particularly the cerebellum, in which diminished Purkinje cell 
number has been reported in a majority of cases (Amaral et al. 2008, Bauman and 
Kemper 2005). This finding has been further supported by well-established 
stereological methods recently performed within our laboratory. Multiple 
theoretical models have been advanced that aim to tie together the diverse 
neuropathological and neurocognitive phenotypes observed in autism, but have 
failed to account for the full spectrum of complex symptomatologies in the entire 
autism population. However, a growing body of neuropathologic data implicates 
inflammatory and cytotoxic processes in individuals with autism of all ages 
investigated, which may provide insight into the development of autism in a 
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subset of the population (Pardo et al. 2009, Li et al. 2009, Castellani et al. 2009, 
Kern and Jones 2006, Molloy et al. 2006, Cohly and Panja 2005, Zimmerman et al. 
2005).  
Specifically, many studies have found increased autoimmune activation in 
those with autism and their close relatives, implying a genetic risk for 
immunopathology in these individuals (Atladóttir et al. 2009, Enstrom et al. 2009, 
Mostafa and Kitchener 2009, Saresella et al. 2009, Garbett et al. 2008, Croen et al. 
2008, Singer et al. 2008, Libbey et al. 2008, Vojdani et al. 2002, Comi et al. 1999). 
Serum antibodies from mothers of children with autism have demonstrated high 
affinity to fetal brain proteins, and been shown to develop stereotypic behavior 
in animal models (Goines and Van de Water 2010, Singer et al. 2008, Patterson 
2009, Wills 2009, Martin et al. 2008). Other studies have highlighted altered 
immune cell activity using in vitro preparations of blood samples from subjects 
with autism (Enstrom et al. 2009, James et al. 2009, Vojdani et al. 2008). Thus, a 
variety of approaches are providing convergent evidence in support of an altered 
immunologic profile in autism of genetic and possibly environmental origin. 
The normal development and function of the central nervous system relies 
heavily on a complex system of cross-talk with cells of the immune system, and 
likewise, innate immunity is dependent on a variety of levels of brain activity in 
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what is termed “the neuroimmune system” (Irwin and Vedhara 2005). For 
instance, the immune cell signaling molecules, cytokines and chemokines, are 
highly potent modulators of brain development, operating at picomolar 
concentrations (Schiepers et al. 2005, Ziv et al. 2006, Stumm and Höllt 2007, 
Filipovic and Zecevic 2008, Schönemeier et al. 2008, Thomas et al. 2009, Palevitch 
et al. 2009, Zhu et al. 2009). Moreover, neurocognitive states have been shown to 
modulate immune reactions through a variety of mechanisms (Tordjman et al. 
1997, Tani et al. 2005, Corbett et al. 2006 & 2008, Dziobek et al. 2006, Theoharides 
et al. 2008, Gamer and Büchel 2009, Gill et al. 2009, Mosconi et al. 2009, 
Schumann et al. 2009), potentially worsening the pathophysiology observed in 
these individuals. 
Through the expression of proinflammatory caspases, microglia and 
astrocytes orchestrate inflammatory reactions in a paracrine fashion, via 
cytokines, chemokines, and prostaglandins (Chakraborty et al. 2010, Chan et al. 
2007). Altered expression of markers of glial activation have been documented in 
many studies of autism (Morgan et al. 2009, Fatemi et al. 2008, Laurence and 
Fatemi 2005, Pardo et al. 2005, Vargas et al. 2005, Ahlsen et al. 1993).  A recent 
PET imaging study analyzing the distribution and extent of gliosis and 
infiltrating macrophages has identified a significant increase in autism (in 
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multiple brain regions including the cerebellum) that was associated with social 
dysfunction as assessed by the ADI-R (Suzuki et al. 2013).  Also, a new method of 
transcriptome analysis has demonstrated increased expression of a set of genes 
implicated in injury, inflammation, and gliosis within postmortem brain samples 
from individuals with autism (Voineagu et al. 2011).  Likewise, oxidative stress, a 
neurotoxic effect of glia-mediated inflammation, has been identified in 
neuropathologic investigations of autism (Chauhan and Chauhan 2006, James et 
al. 2006, Sajdel-Sulkowska et al. 2009). Cytotoxicity can influence a variety of 
cellular processes, but an important correlate that has been observed in 
postmortem autism brain tissue is a pathological shift in the balance of pro- and 
anti-apoptotic signals, favoring cell death cascades (Fatemi et al. 2001, Araghi-
Niknam and Fatemi 2003, Li et al. 2009). All cells are affected by cytotoxicity to 
varying degrees, but cerebellar Purkinje cells represent a uniquely vulnerable 
population. These cells summate over 100,000 excitatory connections, triggering 
calcium influx (Kern 2003, Sugimori and Llinás 1990). Calcium influx is a 
necessary step in apoptosis (Mattson and Chan 2003), which is the mechanism by 
which neurons are lost following excitotoxicity. Purkinje cells are thus quite 
vulnerable to apoptosis-inducing signals, and their loss can affect cerebellar 
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function, as their firing represents the sole source of information transfer from 
the cerebellar cortex to the deep cerebellar nuclei and thus the rest of the brain. 
The pathological processes observed in individuals with autism therefore 
appear to be ongoing throughout life, and could contribute to the increased rate 
of mortality in this population (Pickett et al. 2006, Shavelle et al. 2001), as well as 
the regression of developmental progress seen in a subset of these individuals. 
Factors that lower inflammatory and cytotoxic stress may therefore represent an 
important target for therapeutic intervention in a subset of individuals with 
autism. Along these lines, a recent study has shown that pentoxifylline, a tumor 
necrosis factor alpha (TNFα) inhibitor, lessens autism symptomatology in all 
three core behavioral domains, as assessed by the Aberrant Behavior Checklist, 
with respect to irritability, social withdrawal, stereotypic behavior, hyperactivity, 
and inappropriate speech (Akhondzadeh et al. 2009). TNFα is a pro-
inflammatory cytokine that is found to be over- expressed in the brain in autism 
(Li et al. 2009). Macrophage migration inhibitory factor, which suppresses the 
anti- inflammatory effects of glucocorticoids, was also found to be upregulated in 
individuals with autism, in whom circulating levels correlated with autism 
behavioral symptom severity (Grigorenko et al. 2008). Interestingly, a recent 
study correlated serum levels of bacterial endotoxins typical to the GI tract with 
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markers of immune activation, measures that were correlated with social 
impairment severity on the Vineland Adaptive Behavior Scales and ADI-R test 
batteries (Emanuele et al. 2010). Collectively, these preliminary findings support 
the link between the behavioral impairments observed in autism and adverse 
inflammatory cascades that can be managed pharmacologically. 
One factor that is known to counteract the inflammatory neurotoxic 
events described in the autism literature is the neurohormone, estradiol.  The 
extreme male brain theory of autism (Baron-Cohen 2002) has been supported by 
consistent findings that autism is four times more prevalent in males than in 
females, that individuals with autism have a higher testosterone-estrodiol ratio 
(Hu et al. 2009, Brañas -Garza et al. 2013), and that individuals with autism 
demonstrate more masculinized behavior (Auyeung et al. 2009). Because diverse 
neuroprotective, anti-inflammatory, and neuroregenerative mechanisms have 
been associated with estrogens (Kajta and Beyer 2003, Arnold and Beyer 2009, 
Kipp and Beyer 2009, Saldanha et al. 2009), Keller et al. have studied the effects 
of early estradiol administration on neuropathology in mice bearing a mutation 
in the autism candidate gene, Reln (Biamonte et al. 2009, Ammassari-Teule et al. 
2009, Laviola et al. 2009, Marrone et al. 2006). Reeler mice typically develop 
fewer cerebellar Purkinje cells and fewer interneurons in the amygdala. 
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Additionally, these mice display social and executive function impairments, 
effects paralleling the neuropathology and behavioral symptomatology 
classically observed in autism (Whitney et al. 2008, Whitney et al. 2009, 
Schumann et al. 2009). However, when treated with estradiol, there is a complete 
reversal of these neuropathological and behavioral features (Macrì et al. 2010). 
Reeler mice overexpress neuroinflammatory cytokines (Murase and Hayashi 
2002, Kopmels et al. 1990). Further, prenatal immune challenge has been shown 
to result in decreased Purkinje cells in Crus I & II (Shi et al. 2009), the same 
regions affected in the autistic cases studied by our group.  Additionally, 
decreased reelin protein in the cerebellum in autism has been found to correlate 
with a reduction in anti-apoptotic markers (Fatemi et al. 2001), and estradiol 
administration significantly increases RELN expression (Biamonte et al. 2009). 
We therefore sought to investigate the potential relationship between 
altered estrogen and androgen receptor expression and markers of gliosis and 
immune activation in the cerebellum in autism.  Our regions focused on crus I & 
II within lobule VIIa, an area predetermined to demonstrate the most significant 
neuropathology in autism as evidenced by decreased Purkinje cell density.  Our 
target proteins used to assess gliosis were GFAP and IBA-1, markers of astrocyte 
and microglial activation, respectively.  Increased astrocyte and microglial 
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proliferation has been previously reported in the cerebellum in autism (Vargas et 
al. 2005), and GFAP protein levels have been reported to be increased in the 
cerebellum (Laurence and Fatemi 2005).  An increase in astrocyte and microglial 
proliferation is not necessarily a sign of pathology, however.  Since these cells 
may be stimulated to support homeostatic processes to perhaps improve 
neurotransmission or provide neuroprotection, but in light of the other reported 
findings described above, it is likely that increased glial activation may be 
detrimental to neurons (Sofroniew and Vinters 2010, Luo and Chen 2012).  
Additionally, we chose to assess histamine H1 receptor expression.  Histamine 
represents an important regulator of autoimmunity and inflammation as well as 
neuronal excitability (Nielsen and Hammer 1992, Jutel et al. 2006, Passani and 
Ballerini 2012, Zhou et al. 2007, Tasaka et al. 1989).  Histamine has further been 
demonstrated with electrophysiology to excite Purkinje cells (Tian et al. 2000), 
and is released as a neurotransmitter as well as from mast cells, activating 
microglia (Ferreira et al. 2012).  This is the first study to date to explore histamine 
receptor expression in autism.  We also quantified the relative expression of the 
cytokine, IL-6, as this inflammatory mediator was found to be increased in the 
postmortem cerebella of individuals with autism (Wei et al. 2011).  IL-6 is an 
important cytokine in the central nervous system that has been shown to affect 
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not only inflammation, but also neurogenesis, gliogenesis, cell growth, cell 
survival, myelination and demyelination (Boulanger 2009, Van Wagoner and 
Benveniste 1999, Gruol and Nelson 1997, Gadient and Otten 1997, Van Snick 
1990).  When cultured cerebellar granule cells were induced to overexpress IL-6, 
researchers observed that excitatory synapse formation was stimulated (Wei et 
al. 2011).  This could increase the potential for excitotoxicity in the Purkinje cells 
that receive innervation from these neurons.    Further, researchers demonstrated 
that IL-6 was a key mediator of the cerebellar and behavioral pathology resulting 
from prenatal immune challenges (Smith et al. 2007).  To assess estrogen and 
androgen signaling in the cerebellum, we quantified estrogen receptor β, 
androgen receptor, and aromatase.  Estrogen receptor and androgen receptor 
had previously not been investigated in the cerebellum in autism, but aromatase, 
the enzyme that converts testosterone to estradiol, has been reported to be 
underexpressed (Sarachana et al. 2011).  Purkinje cells strongly express 
aromatase (Fig. 16), and estradiol has been shown to play an important role as a 
local trophic factor  in the cerebellar cortex (Tsutsui 2008).   
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Methods 
Case Demographics 
The cerebella were obtained from the postmortem brains of eleven 
individuals with autism and nine age-matched controls.  Three cases in the 
autism group and two in the control group were females.  All individuals in the 
autism group met DSM-IV and ADI-R criteria for autism spectrum disorders 
(Lord et al. 1994).    The control cases had no known neurological disorder or 
known neuropathology.  The clinical characteristics of each case are summarized 
in Table 4.  Postmortem interval (PMI), or time before initiating brain 
preservation, did not significantly differ between males and females nor between 
autism and control groups.  Also, age did not differ between diagnostic groups.  
One case in the autism group was diagnosed with mild mental retardation (IQ < 
70).  Other clinically relevant features in the autism group included: history of 
seizures (64%), complications during pregnancy (45%), oxytocin-induced labor 
during pregnancy (27%), and irregular pain sensation (36%). One autism case 
suffered from mild developmental regression of fine motor skills. 
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Tissue Preparation 
This study utilized tissue blocks obtained from the lateral hemisperes of 
cerebellar crus I & II in fresh-frozen brains obtained from the Autism Tissue 
Program (ATP).  Whole fresh brain weights were obtained prior to freezing.  
Frozen brains and the tissue blocks dissected for this experiment were stored at -
80°C.   
To prepare samples for protein quantification, the frozen tissue blocks 
were immersed in RIPA buffer, pH 8.0 [150 mM NaCl, 1% NP-40, 0.5% sodium 
deoxycholate, 0.1% sodium dodecyl sulphate (SDS), and 50mM Tris].  The issue 
was immersed in RIPA buffer, supplemented with cOmplete protease inhibitor 
cocktail (Roche, Switzerland), at the concentration of 0.2 gram of tissue/ 1 mL ice-
cold RIPA buffer.  This mixture was homogenized in a dounce glass 
homogenizer on ice, and subsequently centrifuged to remove the protein-rich 
supernatant.   
Total amino acid concentrations of each supernatant was determined with 
a spectrophotometric plate reader (Tecan, Switzerland) using the bicinchoninic 
acid method.  Samples were then diluted with ddH2O to a standard 
concentration of 500 ug/mL.  The supernatants were then prepared for loading 
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into acrylamide gels for electrophoresis by mixing at a ratio of 2:1 with a 
modified Laemmli buffer, pH 6.8 (0.5 M Tris-HCl, 2% sucrose, 10% SDS, 10% 
beta-mercaptoethanol, 0.1% bromophenol blue).  This mixture was heated at 
95°C for 7 min.  Once heated, the proteins are completely denatured and 
prepared for electrophoresis.  The mixtures were then preserved at -80°C until 
utilized in an experiment. 
 
SDS-PAGE and Western Blot Approach 
Polyacrylamide gels were hand-casted using 4% acrylamide solution for 
the stacking layer and 10% for the resolving layer as per BioRad instructions.  
The frozen protein mixtures were centrifuged to facilitate thawing while 
remaining cool, and then 20 ul was loaded into each well of the gel in a random 
order.  The SDS-polyacrylamide gel electrophoresis (SDS-PAGE) was performed 
with an ice pack and constant mixing, with a current of 30mAmps using the 
standard electrophoresis buffer (BioRad, Hercules, CA).   
Once separated by molecular weight, the protein bands within the gel 
were transferred to a PVDF membrane in standard transfer buffer supplemented 
with 10% ethanol, at 40V overnight with an ice pack while mixing at 4°C ambient 
temperature.  The transferred protein bands were then stained for total protein 
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content to control for loading and transfer error in a modified amido black stain 
(7.5% methanol, 10% acetic acid, 0.01% amido black) for 8 minutes, followed by 
two 1-min washes in destain solution (50% methanol, 10% acetic acid), and one 
wash in ddH2O until ready for scanning.  They were scanned (Epson, Perfection 
V750 Pro) using a third-party software (VueScan), which allowed us to obtain the 
raw densitometric data because the Epson software employs post-processing on 
all scanned images.  (The densitometric approach is discussed in the Data 
Analysis section below).  The total protein stain does not disrupt antibody 
binding, and it was determined that optimal signal-to-noise ratios were obtained 
by applying the stain at this stage in the western blot process.   
Following scanning, each membrane was placed in a blocking buffer 
consisting of 3% dry nonfat milk in PBST (0.05% Tween) and incubated at room 
temperature for 1 hr.  Then, each primary antibody was applied at recommended 
dilution for 1.5 hrs at room temperature in PBST with 3% milk blocking buffer 
with constant rocking.  The antibodies are summarized in Table 5.  Following 
primary antibody incubation, the membranes were washed 5 times in PBST and 
then incubated for 1 hr in secondary antibody in 3% milk blocking buffer.  They 
were then washed 5 times in PBST and incubated for 1 hr in streptavidin-HRP 
(Vector Labs, Burlingame, CA) at recommended dilution in PBST. Following 5 
117 
washes, the membranes were treated with a modified ECL solution (0.31mM 
luminol, 1mM 4-iodophenylboronic acid, 1.33mM H2O2) for blot visualization.  
Luminescent signals were detected with a cooled-CCD photodocumentation 
device (Kodak Carestream) at optimized timepoints for each target protein. 
 
Data Analysis 
Densitometry was performed on the raw images collected from the amido 
black-stained as well as luminescent western blot membranes using the 
Carestream Molecular Imaging software.  In the software, identically-sized 
vertical densitometric frames were drawn through the full column of separated 
proteins for each sample and 10mm below each column, and background was 
calculated as the minimum pixel intensity within each frame.  The densitometric 
frames were approximately 30% of the width of the protein column.  Each target 
protein’s densitometric measurement was then corrected for loading error and 
PVDF-transfer inconsistency by dividing it by the corresponding amido black 
measurement.  Further, β-actin blots were performed for each case, and from 
each region, to adjust for differences in postmortem protein degradation.  Each 
target protein’s amido black-corrected value was divided by its corresponding 
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amido black-corrected β-actin value to obtain the final estimate of relative 
protein concentration in the tissue. 
Each target protein blot was done in triplicate (with random sample 
order) and the relative values for each case were averaged.  Results from the 
triplicate blots were highly concordant (the average standard deviation was 14% 
and average correlation was R2 = 0.68, p = 1.52 x 10-3).   
An additional two-tailed t-test was performed for each target protein to 
compare expression in the autism and control groups and none were found to be 
significant.  Therefore, further multivariate tests were not performed.  Such 
comparisons were further corrected for covariance with PMI and age using a 
separate univariate GLM for each protein. 
Pearson correlations were performed to test the association between the 
expression of each protein.  Additionally, protein expression data was correlated 
with nonparametric ADI-R composite behavioral scores using Spearman rank 
correlations. The correlation results were controlled for false discovery rate using 
an adaptive linear approach to estimating q-value (Benjamini 2006).    All 
statistical calculations were performed in SPSS (IBM). 
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Results 
Protein Expression Differences Based on Diagnosis 
 Our investigations found no differences in the target proteins 
investigated on the basis of diagnosis in crus I and crus II (even with t-test 
without false discovery rate control).  Adjusting for covariance with PMI and age 
did not affect the significance of these comparisons.  Figures 17-30 demonstrate 
the spread of data for autism and control groups for each protein. 
 
Protein Expression Correlations and Tests for Behavioral Associations 
 We tested the protein measurements for correlation within each cerebellar 
region to identify physiologically meaningful associations in protein expression.  
A number of significant correlations were identified, but using the false 
discovery rate control limited these findings to a small subset that did not agree 
between crus I & II (Table 6).   
Further, we tested the protein measurements for correlation with two 
ADI-R behavioral composite scores: social impairment, and restricted/repetitive 
stereotypic behavior (some cases were nonverbal, preventing accurate correlation 
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with the communication impairment scores).  None met the cutoff for false 
discovery rate.   
Additionally, despite a wide age range for our study, there was no 
significant correlation between any of the proteins measured and age. 
 
Discussion 
Experimental Design and Summary of Results 
The results of our investigations did not confirm the prior results of glial 
activation and neuroimmune dysregulation in the cerebellum.  Additionally, our 
novel target protein, H1 receptor, did not demonstrate a significant difference in 
expression in autism within lobule VIIa.  We did observe significant correlations 
between a subset of the proteins investigated, but without more detailed 
biochemical analyses, it is impossible to understand the relationship between 
these proteins’ expressions.  Further, the correlations did not agree between 
regions, which indicates that the observed protein associations in each region are 
not ubiquitous but are rather locally regulated phenomena, perhaps by a variety 
of unknown intermediary factors. 
Finally, we did not observe expression differences in estrogen and 
androgen receptors, nor in the enzyme aromatase.  These three proteins had not 
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been previously studied using biochemical methods in autism research; 
however, aromatase had been estimated to be decreased in the cerebella of 
autistic individuals using a semi-quantitative immunohistochemical method 
(Sarachana et al. 2011).  Sarachana found that decreased aromatase expression in 
the cerebellum was associated with lower expression of RORα, a nuclear 
receptor that regulates a number of transcriptional targets in common with 
estrogen receptor.  Mutations in the gene encoding RORα lead to Purkinje cell 
death early in cerebellar development (as is evident in the staggerer mutant 
mouse model which carries a RORα mutation) (Boukhtouche et al. 2006).  RORα 
is also known to directly regulate the ratio between estrogen and androgen 
signaling through controlling aromatase expression (Sarachana et al. 2011).  
Interestingly, RORα is also known to inhibit immune activation (Delerive et al. 
2001, Gold et al. 2007). 
 
Limitations and Methodological Differences across Studies 
The western blot approach faces considerable limitations in its application 
as a quantitative methodology for reliably detecting protein concentrations in 
postmortem tissue.  In theory, western blots provide substantial advantages over 
immunohistochemistry-based quantification.  By first separating a protein-rich 
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solution according to molecular weight via electrophoresis, the methodology 
helps to assure that the target protein is specifically quantified (minimizing the 
contribution of nonspecific antibody binding).  Additionally, the use of tissue 
sections for immunohistochemical quantification introduces a number of 
problems related to uneven thickness across sections, differential light diffraction 
through different tissue compositions within a section (for example, molecular 
layer versus granule cell layer in the cerebellum), and finally the inability to 
correct measures for protein degradation (which is a standard practice in western 
blot  methodology involving correction based on a constitutively expressed 
control protein).  However, western blots introduce new complications: slightly 
differential protein transfer across a membrane, human error in loading proteins 
into gels for SDS-PAGE, and most importantly, the chemical reaction required 
for detection.  We utilized enhanced chemiluminescence (ECL) as our final 
detection reaction because of its wide range of detection and ability to amplify 
signals from even less abundant proteins.  However, as the reaction proceeds 
and photons of light are emitted and captured, the precursor molecules for the 
reaction become less abundant in the microenvironment around a target 
protein’s band (streptavidin-linked horseradish peroxidase must interact with 
scarce H2O2 molecules as well as luminol and its catalyst).  Thus, depending on 
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the concentration of target protein in a particular band, the reaction may reach 
peak photon output at a different time at different sites across the membrane.  
Traditionally, photons were captured using specialized film, which differed 
across companies and products such that some films were more sensitive than 
others, impacting the signal-to-noise ratio.  The advent of photodocumentation 
via cooled CCD-cameras has allowed for much more precise measurement, with 
a much wider range of detection, which is particularly important in human 
studies in which there is substantial inter-individual variability.  Still, the 
problem remains that the time at which an exposure is initiated and the length of 
this exposure will result in differential measurement of the target protein, based 
on the ECL reaction.  One solution to help overcome this has been to generate a 
time-series of photos and then take an integral of the values generated from each 
band, but this process is not standardized and still other problems remain.  For 
instance, if a protein is particularly abundant, it can actually saturate a site on the 
PVDF, causing a ceiling effect on the data generated.  We carefully adjusted our 
protocols to help prevent this, determining the optimal concentration of total 
protein to work with, as evidenced by a wide range of values obtained for each 
measure.  A final issue is the fact that background correction is particularly tricky 
with the western blot, because photons emitted from one band contaminate the 
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measures of neighboring bands.  We attempted to correct for this by 
randomizing sample order and carefully applying background correction to the 
data as described but there is no simple solution to this problem.  With all of our 
efforts to make these western blots most quantitative, we still obtained a 14% 
average standard deviation in the data across triplicate replications of the same 
blot (in terms of final, corrected relative protein expression values).  This 
indicates that there is still substantial variability using this technique, which 
means it is only sensitive to rather large and consistent disease-related changes in 
protein expression.  Yet small changes may still prove quite relevant in the 
pathophysiology of autism, especially for transcription factors like estrogen and 
androgen receptors. 
Perhaps the greatest limitation in the utilization of the western blot as a 
quantitative method is the difficulty comparing across studies: indeed, there are 
as many different techniques as there are labs performing western blots, and the 
methods are constantly being revised.  Overall, we adapted our methods to 
include total protein stains and precise densitometric considerations to avoid 
some of the pitfalls of earlier western blot methodologies (Aldridge et al. 2008, 
Gassmann et al. 2009, Taylor et al. 2013). Indeed, Gassmann et al. found using a 
meta-analysis of 100 recent western blot papers that the substantial confusion in 
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the field about how to appropriately apply densitometry at the end of a western 
blot experiment could lead to final p-values for the same experiment ranging 
from p = 0.000013 to 0.76! 
Without careful consideration of these issues, many researchers are 
obtaining contradictory results with the western blot methodology.  However, 
interestingly, and perhaps due to societal or economic pressures irrelevant to the 
scientific pursuit of knowledge, only a small percentage of research is eventually 
published—the research that has the most exciting and potentially influential 
results (often “statistically significant” findings).  Therefore, many may have 
overlooked the potential unreliability of data generated from a western blot 
study: if 100% of reasonably performed research were published, it is likely we 
would see far more contradiction in the literature.  It is imperative that if western 
blots are to be used quantitatively, a standardized approach must be generated. 
In autism research, this is particularly troubling, because so few cases are 
available for study that theories must be formed based on a small number of 
poorly related cases.  Furthermore, apart from being able to select age- and 
gender-matched controls, extremely little information is known about these 
purportedly “neurotypical” individuals.  In this scenario, the potential for 
spurious findings is maximal, and as discussed in the following Conclusion 
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chapter, it might be time to reassess our research approach to better understand 
not only the relationship between our experimental designs and resulting 
limitations of our data’s implications, but also reevaluate how we can improve 
the questions we ask to truly understand the nature of the complex set of 
disorders collectively known as autism.  Along these lines, we focused on tissue 
quality as a selection factor for the cases in our study, rather than other factors 
that may have affected the probability of identifying neuroimmune pathology.  
For instance, although seizures were noted in 64% of cases in the autism group, 
only one case was reported to experience mild developmental regression, and 
one case was diagnosed with mental retardation.  (In the pivotal paper by Vargas 
et al., 3 cases were reported to have regression, and 80% of autism cases were 
diagnosed with mental retardation). 
An additional issue which has been poorly touched upon in 
neuropathological investigations in this field is the extreme anatomic complexity 
of the cerebellum.  Once viewed as a relatively simply organized system mainly 
responsible for motor coordination, with very little distinction from one folium 
to the next, we are now realizing that there are extremely complex biochemically 
distinct modules within the cerebellum (Ruigrok 2011).  In the current study, we 
attempted to remove tissue from the most lateral aspect of crus I & II for each 
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case, but it is possible that we introduced error into our experiment by sampling 
from different modules within these regions.  Until a better anatomical 
categorization of the cerebellum is performed, with better stereotaxic methods to 
identify the appropriate landmarks for frozen tissue dissection, it will be difficult 
to rule out this complication in future biochemical studies of this extremely 
compartmentalized neural tissue. 
Thus, the present investigation did little to clarify the nature or potential 
relevance of neuroimmune or neuroendocrine complications in the cerebellum in 
autism.  It has demonstrated, however, that there are many obstacles to be 
overcome to adequately assess these questions.  With a large number of studies 
supporting neuroimmune changes in particular, and a wide variety of potential 
treatments to address such issues continually being generated, further research is 
merited. 
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Figure 16. Purkinje cells highly express aromatase. 
Photomicrograph of immunohistochemically stained cerebellar section 
focused on the Purkinje cell layer.  Aromatase was visualized with the 
chromogen, DAB, and a Nissl counterstain was applied. 
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Figure 17. GFAP Expression in Crus I. 
Relative GFAP expression was not significantly different in the autism 
and control groups.  There is one control case with notably increased GFAP 
expression; however, this is not the same case that demonstrated increased GFAP 
in Crus II (Fig. 18). 
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Figure 18. GFAP Expression in Crus II. 
Relative GFAP expression was not significantly different in the autism 
and control groups. 
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Figure 19. IBA-1 Expression in Crus I. 
Relative IBA-1 expression was not significantly different in the autism and 
control groups. 
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Figure 20. IBA-1 Expression in Crus II. 
Relative IBA-1 expression was not significantly different in the autism and 
control groups. 
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Figure 21. Histamine H1 Receptor Expression in Crus I. 
Relative H1 receptor expression was not significantly different in the 
autism and control groups. 
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Figure 22. Histamine H1 Receptor Expression in Crus II. 
Relative H1 receptor expression was not significantly different in the 
autism and control groups. 
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Figure 23. Interleukin-6 Expression in Crus I. 
Relative IL-6 expression was not significantly different in the autism and 
control groups. 
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Figure 24. Interleukin-6 Expression in Crus II. 
Relative IL-6 expression was not significantly different in the autism and 
control groups. 
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Figure 25. Androgen Receptor Expression in Crus I. 
Relative AR expression was not significantly different in the autism and 
control groups. 
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Figure 26. Androgen Receptor Expression in Crus II. 
Relative AR expression was not significantly different in the autism and 
control groups. 
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Figure 27. Estrogen Receptor Expression in Crus I. 
Relative ER expression was not significantly different in the autism and 
control groups. 
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Figure 28. Estrogen Receptor Expression in Crus II. 
Relative ER expression was not significantly different in the autism and 
control groups. 
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Figure 29. Aromatase Expression in Crus I. 
Relative aromatase expression was not significantly different in the autism 
and control groups. 
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Figure 30. Aromatase Expression in Crus II. 
Relative aromatase expression was not significantly different in the autism 
and control groups. 
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Table 4. Case Characteristics 
      (ADI-R Scores for Autism Cases)  
Case Diagnosis Age Gender PMI Cause of 
Death 
Social Non-
verbal 
Verbal Restricted/ 
Repetitive Behavior 
Developmental 
Abnormality 
6736 C 4 F  Pneumonia      
5569 A 5 M 25.5 Drowning 22 14 - 6 5 
5666 A 8 M 22.16 Cancer 19 - 14 4 2 
5342 A 11 F 12.88 Drowning 22 - 14 3 5 
6184 A 18 F 6.75 Seizure 28 - 23 9 5 
5718 C 22 M 21.47       
6221 C 22 M 24.2       
6337 A 22 M 25 Aspiration 28 14 - 6 5 
5601 C 24 M 21.33 Heart Attack      
5000 A 27 M 8.3 Drowning      
6640 A 29 F 17.83 Seizure 30 - 21 12 5 
6994 A 29 M 43.25 Seizure 22 - 16 5 3 
6316 C 32 F 28.92       
6076 C 38 M 25.47       
6401 A 39 M 13.95 Cardiac 
Tamponade 
20 - 12 4 5 
7561 C 39 M  Heart Attack      
6206 C 54 M 24 Heart Attack      
7459 A 54 M 28.25 Cancer      
6200 C 60 M 24.23 Heart Attack      
7090 A 60 M 26.5 Cancer      
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Table 5. Antibodies 
 
Designation 
Target 
Protein Antibody Concentration 
Host 
Species 
1°Ab GFAP ab7260 1:50,000 Rabbit 
1°Ab IBA-1 ab107159 1:1,000 Rabbit 
1°Ab 
H1 
Receptor PIPA518680 1:1,000 Goat 
1°Ab IL-6 ab6672 1:500 Rabbit 
1°Ab AR ab3510 1:1000 Rabbit 
1°Ab Erβ ab3577 1:1000 Rabbit 
1°Ab Aromatase ab18995 1:500 Rabbit 
1°Ab β-Actin ab6276 1:10,000 Mouse 
2°Ab anti-Rabbit BA-1000 1:700 
 
2°Ab 
anti-
Mouse BA-2000 1:700 
 2°Ab anti-Goat PA1-28804 1:5000 
 
Strept-HRP 
(biotin-
2°Ab) SA-5004 1:500 
  
 
Antibody products starting with “ab” were purchased from Abcam (Cambridge, 
MA).  Those starting with “P” were purchased from Thermo Fisher (Waltham, 
MA).  Antibodies and streptavidin starting with “BA” or “SA” were purchased 
from Vector Labs (Burlingame, CA). 
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Table 6. Protein Correlations 
 
Region  Correlation Coefficient (R) p-value q-value (FDR) 
Crus I  aromatase, IL-6 0.79 0.002 0.042 
Crus II  ER, IL-6 0.755 0.0005 0.009 
Crus II  IL-6, GFAP 0.745 0.001 0.009 
Crus II  aromatase, AR 0.698 0.002 0.031 
  
 
The table above represents the significant correlations identified, as controlled by 
false discovery rate (FDR).  Similar correlations were not found in crus I and crus 
II. 
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CONCLUSIONS AND FURTHER DIRECTIONS 
  Chapters 1-3 describe a set of studies designed to better understand the 
neuropathology of autism.  We began by precisely quantifying PC densities 
throughout the cerebellum to assess regional differences in autism. We aimed to 
confirm the hypothesis that the PC density in the posterolateral cerebellar 
hemispheres is more affected than neighboring regions in autism.  We next 
proceeded to perform a study investigating the neurochemistry underlying 
sensorimotor gating, which is reported to be perturbed in autism and a number 
of neuropsychitric conditions. Senorimotor gating is believed to reflect the 
brain’s ability to filter sensory information and inhibit behavior.  Because the 
cerebellum is highly connected with the brain regions involved in sensorimotor 
gating, we hypothesized that the cerebellar neuropathology observed in autism 
may contribute to sensorimotor gating impairments.  In a rat model, we found 
that the histaminergic system regulates sensorimotor gating, and although 
histaminergic neurotransmission has not been studied in autism, it has been 
demonstrated to be increased in a variety of neuropsychiatric conditions that 
display sensorimotor gating impairments. Our study presented in Chapter 3 was 
the first to quantify histamine receptors in autism. We did not find an effect 
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within lobule VII in autistic individuals in H1 receptor binding.  Future studies 
were recommended to better assess the hypotheses investigated in these studies. 
 As touched upon in the introduction, I believe that we have reached a 
point in autism research, such that we should critically look back on all of the 
information we have gathered thus far to reassess our experimental approaches.  
The earliest studies were limited in their technological capacity as well as 
potential to assess the implications of the findings.    Still the cerebellum remains 
an important focus of this disorder.  I question the absoluteness of PC density 
changes being restricted to the prenatal period of autism development.  Not only 
has some data been generated to contradict the theory that inferior olivary loss is 
a certain result of postnatal PC loss, but also, no study has proven the 1-to-1 ratio 
of these neuronal populations in humans.  If the findings of gliosis and 
neuroimmune dysregulation are true in a subset of individuals on the spectrum, 
this dissertation has discussed that a natural assumption would be that PC 
survival would be impacted in these individuals.    Numerous animal models 
have been studied to try to draw parallels between PC pathology and autism 
symptomatology, based on the assumption that these phenomena are directly 
related.  However, the classic cerebellar mutant models involve mutations that 
lead to significantly more extensive PC loss than is commonly reported in autism 
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neuropathological studies.  Meanwhile, these models display typically involve 
degeneration of other neuronal populations.   
It is my hypothesis that similar behavioral autism symptoms could result 
from a variety of pathologies in disparate neural networks that regulate those 
behaviors.    Most agree at this point that autism emerges from a combination of 
factors.  Yet, if we focused more on subgrouping autism based on reliable and 
increasingly characterized endophenotypes, we would be far more successful in 
investigating the development of these more refined subgroups that may share 
more etiological similarity.  We have found many potential endophenotypes to 
begin exploring in detail, but no consensus has been formed about which to 
study collectively.  This categorization process could lead to more effective 
treatment before we even gain appreciable knowledge about each subgroup’s 
physiological distinctions.   
A similar lack of consensus regards the application of our biochemical 
methodology, as presented in Chapter 3.  Comparisons between study findings 
that used different approaches to the same technique are almost impossible to 
reconcile.  To rectify this, we should take the time to perfect a standard approach 
for optimizing a technique, and then labs can make adjustments but still provide 
data using the decided upon approach for comparison.    
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It is my hope that this dissertation will in the very least incite more critical 
review of where we’ve been and where we’re currently heading in the autism 
research field.  I’ve presented data using three very distinct methodologies, and 
explored how the findings relate to the autism literature.  Although no major 
translatable discoveries were presented, it is my belief that with better 
experimental design and reevaluation of the research questions we are asking, 
we can eventually split autism into many subtypes that can be better understood 
and eventually benefitted. 
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